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ABSTRACT
Unlike univariate phenotypes such as human height, multivariate phenotypes such
as substance use disorders, are characterized by multiple low level phenotypic features.
Due to the substantial variation in the multivariate features, these phenotypes are
heterogeneous. This phenotypic heterogeneity substantially limits the success in uncovering genetic factors of the phenotype. The identification of homogeneous disease
subtypes can be both necessary and beneficial. Despite great progress in molecular
genetics that allows the genomewide identification of common and rare variants, there
is considerably less progress in the refinement of phenotypes.
The most recent and sophisticated phenotype refinement approaches perform unsupervised cluster analysis to partition a sample population into subgroups based only
on the phenotypic features. Since genotypic data are not used to guide the derivation
of subtypes, the resultant subtypes may differ only in phenotypic features and thus
have limited utility in genetic association analyses. In this thesis study, we propose to
refine a multivariate phenotype by simultaneously modeling both phenotypic features
and genotypic markers. Two integrative approaches are investigated.
In the first approach, we propose a multi-view cluster analysis to identify clusters
of subjects that agree across the two views - phenotypic view and genotypic view. Two
different algorithms have been developed along this line. Based on multi-objective
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programming, the first algorithm integrates a cluster analysis on phenotypic data and
classification on genotypic data by simultaneously optimizing two objectives: (1) the
resultant clusters should differ significantly in phenotypic features; (2) these clusters
can be well separated using genetic variants via classifiers. Based on sparse matrix decomposition methods, the second algorithm simultaneously decomposes the two data
matrices of phenotypic features and genotypic markers into factorized components
that share a common structure. This algorithm jointly groups rows (forming subject
clusters) and columns (features that determine the subject clusters) of a matrix, and
the resultant row groups are consistent across the two matrices.
In the second approach, we propose to use heritability to guide the subtype derivation. Heritability measures the genetic contribution to the variation of a trait, and is
commonly estimated from related individuals in pedigrees. The availability of dense
genomewide markers allows heritability to be directly estimated from unrelated individuals and their genomewide single nucleotide polymorphisms (SNPs). We have
hence developed two algorithms that identify disease subtypes with high heritability. The first algorithm takes family pedigrees as genetic inputs whereas the second
takes genomewide SNPs. Both algorithms derive subtypes as a linear combination of
phenotypic features and this combination is obtained by maximizing the likelihood
of observing a high pedigree-based or SNP-based heritability.
All proposed algorithms were first validated in simulation studies. The validated
algorithms were then used in case studies to analyze real-life datasets that were aggregated from genetic studies of drug dependence including opioid and cocaine dependence. These empirical studies demonstrate the superior performance of the proposed
approaches over the state of the art.
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Chapter 1
Introduction

1.1

Motivation and Challenges

Complex phenotypes are often characterized by multiple low level phenotypic features,
and are thus multivariate. For instance, the substance use disorder is a complex
human disease with multivariate phenotypes. In order to diagnose whether a patient
has a lifetime drug dependence, clinicians interview the patient to understand the
patient’s drug use behaviors, the negative consequences of drug use, treatment history
and other co-occuring medical conditions. All of these clinical variables are used to
arrive at a diagnosis of dependence on a certain drug [59]. In agriculture, breeding
programs targeted at conceptual but economically important phenotypes, such as feed
efficiency or heat tolerance of animals, are confronted with a wide variety of available
multivariate measures [18, 12]. Residual body weight gain, residual feed intake or
relative growth rate are feed efficiency measures for dairy cattle [7, 18]. All these
measures are multivariate phenotypes that are defined by aggregating many low-level
1
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variables, such as body weight, diet and feed energy intake, and days in milk.
Identifying genetic variation that underlies complex phenotypes has important
implications in both biology and medicine. For example, it helps elucidate the biological processes that moderate or regulate a complex disease, such as cancer, heart
disease, and substance use disorders, and thus facilitates the development of more
effective treatments. To date, over 2,000 genome-wide association studies (GWAS)
have been conducted by investigators world wide. These studies have identified a
large number of common and rare genetic variants associated with common traits
[44]. Despite these successes, a large portion of the trait heritability has not been
explained by GWAS. Statistical genetics shows that the success of genetic correlation
with a complex phenotype is dependent on two major factors: (1) the availability
of comprehensive genetic variants, and (2) the quality of the phenotype. Phenotype
refinement can hence play a significant role in enhancing genome-wide associations.
Novel statistical and quantitative techniques are needed to refine the phenotypes of
complex disorders, which is an important area of genetics research currently underdeveloped.
Case-control analyses are commonly used in the GWAS of complex diseases where
the diagnosis itself induces a binary trait that partitions the population into cases
(subjects with the disorder) and controls (subjects without). Although the disease
indicators used to arrive at the diagnosis vary significantly among the individual
cases, the binary trait cannot reflect this heterogeneity. This binary approach cannot
distinguish the heterogeneous clinical manifestations that may be attributable to
distinct causal effects from genetics and/or environment. Moreover, the diagnosisinduced traits often have low heritability and are suboptimal for genetic association
analyses [41]. Hence, GWAS have had limited success in dissecting genetic etiology
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of complex diseases. For substance use disorders, very few associations have been
identified at the genome-wide significant level that can be replicated [25, 23, 71]. The
substantial phenotypic heterogeneity has been one of the main factors limiting the
success of GWAS [71].
In the effort of phenotype refinement to identify phenotypes that are suitable
for genetic analysis, researchers can perform a simple phenome scan to assess the
heritability of individual low-level phenotypic features that are used to characterize
the overall complex phenotype. Using individual phenotypic features as traits in genetic association analysis cannot capture the phenotypic heterogeneity either because
genetic associations with a single clinical feature may not explain the phenotypic variance in other disease-defining features. This univariate approach also cannot model
the interplay between low-level phenotypic features. It cannot answer the question of
whether a specific but unknown combination of several features would form a multivariate phenotype that has higher heritability and is more informative in genetic
studies.
Multivariate data mining of low-level phenotypic features has seldom been utilized.
Prior to the proposed research in this thesis study, the most sophisticated phenotypic
refinement methods come from multivariate cluster analysis and latent class analysis
that have been mainly used to subtype human disease phenotypes [15, 41, 53, 26, 27].
Traditional clustering algorithms such as k-means [61] and hierarchical clustering [60]
have been extensively applied to phenotype complex diseases [79, 82, 14, 13]. Many
of the studies lack a quantitative and objective measure to validate the clusters.
Cluster analysis requires that the subtypes differ significantly on the disease-specific
phenotypic parameters that are used.
More recently, heritability was used to assess the validity of the subtype clusters
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[27, 15]. Because the power of most gene discovery studies is positively associated with
the trait heritability [4], heritability can be a valid target for refinement. Heritability
is a key population parameter that helps understand the genetic architecture of a phenotype. The narrow-sense heritability h2 is defined by the percentage of phenotypic
variance that is due to additive genetic effects [32]. The broad-sense heritability H 2 is
defined as the overall genetic contribution to the phenotypic variation. The heritability of a quantitative trait is commonly estimated from related individuals in family
pedigrees. Recent advances in acquiring dense genome-wide genetic markers have
enhanced heritability estimation from apparently unrelated individuals using their
genome-wide single nucleotide polymorphisms (SNPs). The SNP-based heritability
is defined as the portion of the phenotypic variation that can be explained by the
genotyped genetic markers [84]. If a phenotype has higher heritability, it is more genetically influenced, and thus there is greater chance to detect its causative variants.
There are widely-used heritability estimation methods, such as sequential oligogenic
linkage analysis routines (SOLAR) software [3] that can estimate the heritability of
a trait from pedigrees, and the genome-wide complex trait analysis (GCTA) software
[84] that can estimate the SNP-based heritability of a quantitative trait.
Figure 1.1.1 shows the flowchart of a common approach [26, 27, 57] for phenotypic
subtyping. First, a standard clustering strategy, relying either on a single clustering
method or k-means combined consecutively with hierarchical clustering, is applied to
the phenotypic data to partition the sample. It assigns each subject to a specific cluster. Then, to form a quantitative trait (or a multivariate phenotype), a classification
approach, typically logistic regression, is used to learn a classifier in the objective of
separating subjects in different clusters. The learned classifier is a function of phenotypic features involved in previous cluster analysis and gives a membership score to
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each subject with respect to a cluster. The classifier is expected to report a higher
membership score for subjects in a specific cluster than those who are not. The
score computed for each subject is regarded as a quantitative trait characterizing the
specific cluster, and its heritability is estimated using software such as SOLAR [3].
This approach is limited by the fact that, although heritability is used to validate the
clusters, it is not used in the creation of the clusters. Thus, the resultant quantitative
traits are not guaranteed to achieve high heritability.

Figure 1.1.1: A common approach to phenotypic subtyping.

In our early work [66], an approach was proposed to identify stable and heritable subtypes of opioid use and related behaviors using a three-step sequence: variable selection, clustering, and classification. This approach advanced the subtyping
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methodology by assuming that highly-heritable traits can be derived based on the
clinical features that are also heritable. In the variable selection step, clinical features were selected based on their estimated heritability and used in cluster analysis.
This method resulted in two highly-heritable opioid-use subtypes [66]. However, there
are several limitations that may prevent successful applications of this approach to
other data sets. First, some of the clinical features are binary traits, such as the
response variable to a question of “have you used opiates more than 11 times in your
lifetime?” is binary with two possible answers “Yes” or ‘No”. It is not straightforward to estimate the heritability of a binary trait. Second, it is unclear that simply
combining highly heritable clinical features will necessarily lead to traits that are
more heritable. Third, similar to the standard clustering approach reviewed above,
heritability was not used directly in the clustering process.
Hence, in this dissertation work, we propose and investigate a series of new statistical models and algorithms that aim at identifying more genetically influenced traits
and thus more suitable for use in genetic studies. Our approach consists of a set
of integrative analytics that jointly models phenotypic features and genetic markers.
The phenotypic features include clinical symptoms and disease indicators used in a
diagnosis. The genetic inputs can either be family pedigrees of the study samples or
their genetic variants (or genotyped markers).

1.2

Overview

Our approach aims to derive multivariate analytic algorithms based on quantitative
genetics theory [4], statistical learning theory [31, 74] and theories of substance use
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disorders that emphasize the multifaceted nature of substance use and related behaviors [5, 50, 80], and then use these new theory-driven algorithms to analyze empirical
data. For instance, the proposed statistical methods to identify highly heritable traits
will be derived from heritability estimation [21], and the joint analysis of clinical and
genomic data will be based on multi-view data analytics [11, 42]. Figure 1.2.1 depicts
an overview of the proposed techniques and algorithms.

Figure 1.2.1: Overview of the proposed research.

First, we propose multi-view clustering methodologies to identify a grouping of
subjects that agrees when subjects are clustered based on, respectively, their phenotypic data and genotypic data. Two algorithms have been developed for different
purposes. The first one is used to create clusters and simultaneously quantify the
predictive power of the genetic markers for the identified clusters. The second algorithm focuses on the identification of phenotypic clusters that can be associated with
certain genetic markers, but will not be able to quantify the predictive power of the
genetic markers for the clusters.
Based on multi-objective programming, the first algorithm is capable of clinically
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categorizing a disease phenotype so as to discover genetically different subtypes. This
method performs two tasks: a cluster analysis in the phenotypic view and classification in the genotypic view by jointly optimizing two objectives. One objective requires
that the derived clusters differ significantly on clinical features. The other objective
requires that these clusters can be well separated using genetic markers by classifiers.
The classifiers are constructed as a function of genetic markers to separate subjects in
the different clinical clusters. Extensive experiments have been conducted for two substance use disorders: opioid and cocaine dependence, using two populations: African
Americans and European Americans. The experimental results demonstrate that the
proposed method is superior to existing subtyping methods.
Based on multi-view matrix decomposition, the second algorithm integrates clinical features with genetic markers to detect subtypes with confirmatory evidence in
both data sources. This approach groups subjects into clusters that are consistent
between the phenotypic and genotypic dimensions of data, and also simultaneously
finds the clinical features that define the cluster (subtype) and the genetic variants
that are associated with the subtype. A simulation study validates that the proposed
approach indeed identifies hypothesized subtypes and their associated features. The
comparison with the latest biclustering and multi-view clustering methods on our
real-life disease data shows that the proposed approach can identify genetically more
separable clinical subtypes of a disease, thus demonstrating the superior performance
of the proposed approach.
Second, we propose to derive subtypes or subphenotypes of a complex disease
that are optimized with respect to heritability because heritability is a good indicator
for the utility of the subtypes as traits in genetic association analysis. The resultant
subphenotypes, characterized by quantitative traits, will achieve high heritability as
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measured either by the traditional narrow-sense heritability or the recent SNP-based
heritability. Two different such methods have been developed to accomodate the
different types of genetic data - pedigrees or genetic markers.
In the first method, we consider family pedigrees of a study sample as the genetic input. This method searches for the linear combinations of phenotypic features
that can maximize the heritability estimate of the resultant quantitative traits. A
quadratic optimization problem is formulated by decomposing the traditional maximum likelihood method for estimating heritability of a quantitative trait. An efficient algorithm is developed to solve the proposed optimization problem following the
framework of sequential quadratic programming (SQP). We have further extended our
formulation to model covariates, such as age, sex and race, which can then identify
subtypes of a complex disease that have high heritability even after correction for
fixed effects of the covariates. We demonstrate the effectiveness of this method on
synthetic data as well as in the analysis of real-world data. We applied our algorithm
to identify highly heritable traits of substance use disorders including opioid and cocaine dependence. Our approach outperformed standard cluster analysis and several
previous methods.
Due to the rapid advances in genotyping technologies, the availability of genomewide genetic markers becomes much greater for genetic studies of multivariate phenotypes, such as substance use disorders. On the other hand, it is commonly difficult to
recruit related family members in a genetic study of such a disorder. The majority of
existing datasets contains unrelated individuals. The genetic relationship of unrelated
individuals can be better estimated from the genome-wide sample of SNPs. Hence,
our first method based on related individuals of pedigrees is not readily applicable to
these datasets. In the second method, we take genome-wide genetic variants as the

10
genetic input when maximizing the heritability of a derived subtype. This method
also searches for linear combinations of phenotypic features. The difference is that the
resultant linearly-combined trait maximizes the SNP-based heritability (also referred
to as the chip heritability). The objective function of this optimization problem is
formulated by decomposing the restricted maximum likelihood method that is used
to estimate chip heritability. We also take into account the covariate effects so that
the derived traits will still have high chip heritability after correcting covariate effects.
An efficient SQP based algorithm has also been developed to solve this optimization
problem. Extensive empirical studies were conducted, demonstrating the effectiveness
of this method as well.

Chapter 2
Multi-view Co-modeling to
Improve Subtyping and Genetic
Association of Complex Diseases

2.1

Introduction

In a subtyping study, an objective function may be used to evaluate how strongly
the subtypes derived from the grouping are associated with a given set of genetic
markers, or how well the subtypes can be separated by the genetic markers. Mathematically, given two sets of variables, clinical features Z and genetic markers X from
the same sample, the goal is to partition the sample into subgroups based on pairwise
similarities between subjects in Z so that the resultant subgroups y can be classified
by X. This problem is different from traditional supervised or unsupervised machine
learning problems where labels of subjects are either given precisely or not given at
all. In our problem, the labels of subjects need to be derived from the clinical features
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Z so they can be used to train a classifier with the genetic data X.
In the machine learning literature, the most related work might be the set of
multi-view data analysis methods, co-training methods [11] and co-clustering methods [42] where multiple groups of input variables are collected for the same set of
subjects. When only a small portion of the data is labeled, co-training improves the
classification accuracy by enforcing consistency between the classification decisions of
the unlabeled data determined by the models learned independently from each of the
views. Nevertheless, co-training methods are not applicable to the subtyping problem
because there are no labeled data to start with. Multi-view clustering methods seek
groupings of subjects that are consistent across different views. These methods treat
the data from the two views equally as the input variables. In the subtyping problem,
however, the two views have to be treated differently in that one is used to define the
subtypes y and the other is used to explain them. For instance, only a sparse set of
genetic risk markers are identified to be associated with a subtype but the subtypes
may be defined using many clinical features.

2.2

Proposed Methodology

We propose a multi-objective optimization framework to solve the subtyping problem.
For a set of cluster labels y, each assigned to one subject, we construct a model as
a function of a subject’s genetic markers X to approximate the subject’s label. The
model M is built by minimizing a loss function `(y, X|Mθ ) where Mθ is a specific
inference model, such as the model of support vector machine (SVM), or logistic
regression, and θ denotes the set of its parameters. Since the labels y of subjects are
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not given beforehand, the labels themselves need to be derived. In other words, we
optimize the objective as follows

min `(y, X|Mθ ) + λR(Mθ )
y,θ

(2.2.1)

for the best y and θ where R(Mθ ) defines the regularization term that controls the
complexity of the model M , and λ is a tuning factor to balance between ` and R.
Notice that not every possible labeling y of subjects is a feasible solution of Problem
(2.2.1). The search space of y is confined by the similarity measure defined on the
features Z.
Suppose that the classification of subjects y is obtained by partitioning subjects
based on a similarity measure that is pre-specified on Z. The parameters used in
the similarity measure often need to be tuned, such as the parameter σ if a Gaussian similarity exp(−||Zi − Zj ||2 /σ 2 ) is used where Zi and Zj are the two vectors of
clinical features for Subjects i and j. Choosing different values of σ or other relevant
parameters will produce different clusters of the subjects. In general, we expect that
the resultant clusters will be well differentiated from each other and that subjects in
the same cluster will be closer than those from other clusters in the Z space. Many
metrics have been derived in the literature to measure the quality of clusters, such
as the Dunn’s Validity Index [20], Davies-Bouldin Validity Index [19], and Silhouette
Validation [62]. If a metric (y|σ, Z) is employed to measure the quality of clusters
when using a specific value of σ, the metric corresponds to another objective of the
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subtyping problem. We hence optimize simultaneously two objectives as follows


 Obj1 : (y|σ, Z)
min
y,θ,σ 
 Obj2 : `(y, X|Mθ ) + λR(Mθ ).

(2.2.2)

We assume that (y|σ, Z) is a metric to be minimized, or otherwise it can be inverted
or negated. The two objectives of Problem (2.2.2) may not be optimized at the same
solution. Thus, it formulates a multi-objective optimization problem.
Multi-objective programming (MOP) is a technique that was developed to solve
optimization problems with multiple conflicting objectives. Solving a multi-objective
program requires the search for Pareto-optimal solutions [8]. Traditional methods
convert multiple objectives into a single objective using certain schemes and userspecified parameters. Two simple and widely used methods for such conversions are
the weighted sum method and the constraint method [8]. The weighted sum method
transforms two objectives into a single objective by multiplying each objective with
a pre-defined weight and adding them together as follows

min c1 Obj1 + c2 Obj2

(2.2.3)

where the weights c1 and c2 are non-negative and at least one of them is not zero.
If the MOP is not convex, the non-convex frontier of the Pareto-optimal set cannot
be obtained by the weighted sum method. The constraint method reformulates the
MOP by keeping one of the objectives and restricting the rest of the objectives within
user-specified limits, such as,

min Obj2 , subject to: Obj1 ≤ δ.

(2.2.4)
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Our MOP-based subtyping framework follows the constraint method, and can
be implemented using any proper cluster analysis algorithm to optimize Obj1 , and
any suitable classification algorithm to optimize Obj2 . In the next section, we will
instantiate this methodology by utilizing a spectral clustering method [48] and the
one-norm SVM [86] in the MOP.

2.3

Multi-objective Optimization Formulation

A spectral clustering method [48] is employed to search for the cluster assignments
of subjects by varying the parameter σ in its Gaussian similarity measure. The
Davies-Bouldin Validity Index [19], measuring how significantly the resultant clusters
differ from each other, serves as Obj1 . The one-norm SVM [86] is used to build a
classifier, as a function of the genetic variables X, that separates subjects in different
clusters. The loss function used in the one-norm SVM serves as Obj2 . Notice that
the framework (2.2.2) can be realized in conjunction with other choices of clustering
and classification methods.

2.3.1

The Clustering Algorithm

Spectral clustering is a method based on undirected similarity graph G = (V, E)
in which each node in V represents a data point (a subject) and each edge in E is
weighted by the similarity between the two connected data points. Partitions of data
points represented in the similarity graph can be obtained by cutting the graph into
unconnected components with the minimum cost. In a balanced cut, the sizes of these
unconnected components should be comparable. Two methods have been proposed
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to achieve this kind of balanced cut, RatioCut [30] and Ncut [64], that minimize the
following objectives, respectively,
P
i ,C̄i )
= T r(H T LH)
RatioCut(C1 , ..., Ck ) := 21 ki=1 A(C
|Ci |
P
i ,C̄i )
N cut(C1 , ..., Ck ) := 12 ki=1 A(C
vol(Ci )

(2.3.1)

= T r(T T D−1/2 LD−1/2 T )

where Ci is one of the identified components (clusters), |Ci | and vol(Ci ) denote the
number of nodes and the sum of edge weights in Ci respectively, and C̄i consists of
the nodes that are not in Ci . The matrix A = {aij } is the adjacency matrix and aij
measures the similarity between the nodes i and j, D is a diagonal matrix whose ith
P
diagonal element dii = j:j6=i aij , L is the graph Laplacian defined by L = D − A,
T r(·) means the trace norm, and both H and T are matrixes consisting of indicator
vectors as columns defined as follows:
H = [ √1 11 , ..., √ 1 1k ]
|C1 |

T = D1/2 [ √

|Ck |

1
vol(C1 )

1
11 , ..., √vol(C
1k ]
)

(2.3.2)

k

where 1i is an indicator vector whose entries equal 1 if the corresponding nodes are
in Ci , or 0 otherwise. Finding the global optimal solution to either of these two
objectives is NP hard [76]. Their relaxed versions have been defined by allowing
the indicator vectors in H and T to take real values. It has been shown that the
optimal solutions to the relaxed problems of RatioCut and Ncut are the matrices
composed by the eigenvectors corresponding to the first k smallest eigenvalues of L
and D−1/2 LD−1/2 , respectively [48].
In spectral clustering, the clusters are determined by the adjacency matrix A
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which is further determined by a pre-chosen similarity measure. Spectral clustering is
sensitive to changes in the similarity measure [48]. In our approach, we search for the
most suitable similarity measure, more precisely, the best value of σ in the Gaussian
similarity, to optimize Obj1 and Obj2 .

2.3.2

The Objectives in Our Multi-objective Program

(1) First Objective. Spectral clustering requires an adjacency matrix A that encodes
the pairwise similarities between subjects and the desired number of clusters k as
its inputs, and outputs the clusters Ci of subjects, i = 1, · · · , k. In our approach,
we search for the best value of σ in the Gaussian similarity measure to optimize the
Davies-Bouldin Validity Index (DBVI) [19] that measures the quality of the clusters.
DBVI is a measure related to the ratio of within-cluster distance to between-cluster
distance. The lower value of DBVI indicates better quality of the clusters. Hence, we
minimize the DBVI as follows using Ncut [64] for the best σ
k

min DBVI =
σ

1X
Dist(Ci ) + Dist(Cj )
max
k i=1 i6=j
Dist(Ci , Cj )

(2.3.3)

where Dist(Ci ) is the average distance from each data point in Ci to the cluster
center, Dist(Ci , Cj ) is the distance between the center of Ci and the center of Cj .
These distances are calculated in the Z dimension.
(2) Second Objective. For each cluster Ci , without loss of generality, we construct
a classifier in the linear form of f (X) = W T X + b to separate the subjects in Ci
from the remaining subjects. The model WiT X + bi specific for Cluster Ci is obtained
by minimizing the regularized empirical error `(yi , X, Wi ) + λR(Wi ) where we use
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a binary vector yi to indicate the cluster membership: yij = 1 if subject Xj is in
Ci , or otherwise yij = −1, j = 1, · · · , n, for all n subjects. We employ the hinge
n
X


loss commonly used in SVMs, e.g., `(yi , X, Wi ) =
1 − yij WiT Xj + bi + where
j=1

[a]+ = 0 if a < 0, otherwise [a]+ = a, and R(Wi ) takes a sparse-favoring form in
P
order to select among features, in particular, `1 -norm ||Wi ||1 = d |Wid |. The `1 norm shrinks the coefficients W of irrelevant variables to zero [86]. Constructing all
of the k classifiers together corresponds to minimizing the overall regularized error as
follows:
min

k
X

Wi ,bi ,i=1,··· ,k

[`(yi , X, Wi ) + λR(Wi )]

(2.3.4)

i=1

(3) Constrained Conversion. Clearly, the first objective is not convex, which leads to a
non-convex multi-objective program. The constraint conversion method is more suitable to find the Pareto-optimal solutions to this problem. As the subtyping problem
seeks to obtain clusters that are interpretable in the X dimension (genetic markers),
we model the first objective as a constraint. In other words, we search for solutions
that minimize the second objective subject to an acceptable quality of clusters in the
Z dimension (clinical features). The following problem (2.3.5) is the problem we will
solve.
min
σ, Wi , bi

k
X



n h
i
X


1 − yij WiT Xj + bi
+ λ||Wi ||1 

i=1

+

j=1

i = 1, · · · , k

(2.3.5)
subject to

1
k

k
X
i=1

max
i6=j

Dist(Ci ) + Dist(Cj )
≤δ
Dist(Ci , Cj )

lσ ≤ σ ≤ uσ

where δ, lσ and uσ are tuning parameters to bound σ.
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2.3.3

The Proposed Algorithm

Traditional methods for finding the optimal solution to a constrained optimization
problem include deterministic approaches such as gradient-based methods, Newton’s
methods, and non-deterministic approaches such as simulated annealing [39]. To
avoid the difficulty of computing derivatives of the objective function, we design an
efficient algorithm based on simulated annealing to solve the converted MOP (2.3.5)
as depicted in Algorithm 1.
Algorithm 1

Simulated Annealing for MOP (2.3.5)

Input: Z, X, k, δ, MI
Initialize: σ, T , h = 0;
for t = 0 to MI do
Calculate Temperature T ;
Find a neighbor of σ to obtain σnew based on T ;
Construct adjacency matrix A using Z and the Gaussian similarity with σnew ;
Obtain clusters Ci , i = 1, · · · , k, by running Ncut with A and k;
Calculate Obj1 in (2.3.3) and assign its value to q;
if q ≤ δ then
Compute Wi , bi for each Ci separately by the one-norm SVM;
Calculate Obj2 in (2.3.4) and assign its value to hnew ;
else
Continue;
end if
if probability(h, hnew , T ) > random(0, 1) then
h = hnew , σ = σnew ;
end if
end for
Output: clusters Ci:1,...,k , the values of Obj1 and Obj2 .

In Algorithm 1, the temperature T starts from a high value, and decreases gradually at each iteration. A probability density function defined according to T is used
to search for σnew . The first objective is evaluated after the clusters are obtained.
If this objective is within the pre-specified limit δ, an SVM model is constructed for
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each cluster, and the second objective is evaluated. The probability of accepting σnew
is calculated via the acceptance probability density function discussed in [37] and
defined by the objective values h, hnew and the temperature T . If this probability is
larger than a number randomly drawn from [0, 1], σnew is accepted; or otherwise the
previous value of σ is retained. Readers can consult with [37] for more discussions on
simulated annealing.

2.4

Computational Results

We applied the proposed algorithm to two real-world data sets that were aggregated
from genetic studies of opioid dependence (OD) and cocaine dependence (CD) [15,
66, 41, 24]. We limited the analysis to European Americans to avoid confounding by
population differences in allele frequencies and structure. We compared our approach
to an existing subtyping method that performed a sequence of two separate steps:
spectral clustering and one-norm SVM classification in the same fashion as in [15]. We
refer to this as the sequential subtyping method. The two approaches were compared
in terms of the separability of their resultant clusters based on genetic markers.

2.4.1

Data sets

Subjects were recruited from multiple sites, including Yale University School of Medicine,
University of Connecticut Health Center, University of Pennsylvania School of Medicine,
McLean Hospital and Medical University of South Carolina. All subjects gave written, informed consent to participate, using procedures approved by the institutional
review board at each participating site.
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Table 2.4.1: Summary of the OD and CD data sets
Dataset
opioid
cocaine

#cases
827
1279

#controls
643
187

#Vars
69
68

#MCA Dims
13
25

#SNPs
1185
1248

Opioid use and cocaine use behaviors were assessed by two separate components
dedicated to the diagnosis of OD and CD respectively in a computer-assisted interview
process, called the Semi-Structured Assessment for Drug Dependence and Alcoholism
(SSADDA) [59]. The SSADDA variables selected by previous OD and CD subtyping
studies [41, 15] were used in the present analysis. Multiple Correspondence Analysis
(MCA) [51] was performed to reduce data. The top MCA dimensions that overall
explained more than 80% of data variance were used in cluster analysis.
A total of 1350 single nucleotide polymorphisms (SNPs) selected from 130 candidate genes were genotyped for association tests [34]. For each dataset, we performed
quality control as follows. SNPs for which data were available for less than 95% of
the subjects, or for which the P-value for Hardy-Weinberg equilibrium was less than
10−7 were excluded from further analysis. The minor allele frequency (MAF) of each
SNP was calculated within each population. SNPs with MAF less than 0.5% in a
population were removed from the association tests for the respective population.
The remaining missing entries in the SNP data were imputed.
For the OD data set, we treat opioid users as cases and healthy subjects as controls.
For the CD data set, subjects who were diagnosed with cocaine dependence were
treated as cases and healthy subjects who had been exposed to illicit drugs were
regarded as controls. Table 2.4.1 summarizes the statistics of the two data sets in
terms of the numbers of cases, controls, SSADDA variables (Vars), MCA dimensions
(Dims), and SNPs used in the subtyping analysis.
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2.4.2

Experimental settings

We utilized the CPLEX optimization package to solve the one-norm SVM, and implemented spectral clustering in MATLAB. Adaptive simulated annealing, an open
source variant of simulated annealing, together with its MATLAB gateway (ASAMIN
v1.39) was used to search for the value of σ that optimizes the multi-objective program (2.3.5). The parameters δ, λ were set to 0.7 and 0.08 respectively. The upper
bound of σ, uσ was set to a number that led to a pairwise similarity value of at least
0.99, and the lower bound of σ, lσ was set to the value producing a similarity matrix
of the median value less than 0.0001. These tuning steps were based on 3-fold cross
validation.
A typical way to choose a value for σ is to use the median value of all entries in
the pairwise distance matrix [48]. We fixed σ to the median value in the sequential
method. For both the proposed and sequential methods, cluster analysis was only
applied to cases. The resultant clusters were characterized based on important clinical
features related to drug use and related behaviors. A generalized estimating equation
(GEE) Wald Type 3 χ2 -test was employed to test the significance of the difference
between the resultant clusters in these clinical variables with Bonferroni correction
for multiple comparisons.
For each obtained cluster, an SVM model was built to separate cases in the cluster
labeled as +1 from controls labeled as −1. SVM is sensitive to unbalanced data where
the size of a sample with one label is significantly larger than that with another label.
To address this problem, we duplicated subjects in the smaller group to make the
sample size of the two groups comparable. Let a and b be the dominating and minor
groups, respectively, na and nb be their sample sizes, and t = bna /nb c. We first
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duplicated each subject labeled by b t times, and then randomly selected na − t ∗
nb subjects from the sample pool composed by all subjects with label b. Ten-fold
cross validation with stratified case-control split was conducted for every cluster,
and receiver operating characteristic (ROC) curves were obtained using the test data
combined from all folds to evaluate the classification performance. We provide the
Area Under the ROC Curve (AUC) in our results to compare the two methods. The
AUC reflects the cluster separability based on genetic markers.
Moreover, different analytic approaches, such as SVM, or logistic regression, may
identify important SNPs of different associative effects. A larger coefficient for a
SNP in the SVM models does not necessarily translate into a smaller p-value in
logistic regression. We further tested each of the selected SNPs, i.e., those with none
zero coefficients in the SVM models, by a separate logistic regression and evaluated
their corresponding p-values to determine the significance of the association with the
identified subtypes. Here, logistic regression models were obtained in the similar
sampling scheme introduced early on to balance the data.

2.4.3

Opioid use subtypes

We set the desired number of clusters to 2, so that the resultant clusters were sufficiently large and gave adequate statistical power. The optimal value of σ found by
our approach was 5.8.

Cluster Clinical Characteristics
We characterized the two clusters obtained with σ = 5.8 based on 11 important
clinical variables depicting opioid use and its consequences. Table 2.4.2 shows that

Age of first use [Mean (SD) in year]
Used opioids daily or almost daily
Injected opioids intravenously
Stayed high from opioids for a whole day or more
Strong desire for opioids made it hard to think of anything else
Opioid use interfered with work, school, or home life
Family members, friends, doctor, clergy, boss, or people at work
or school objected to opioid use
Been arrested or had trouble with the police because of opioid use
Give up or greatly reduced important activities due to opioid use
Ever treated for an opioid-related problem
Ever attended self-help group for opioid use

Behaviors

Cluster 2
170(20.56)
21.67(7.71)
107(62.94)
50(29.41)
103(60.59)
50(29.41)
39(22.94)
52(30.59)
23(13.53)
48(28.24)
37(21.76)
23(13.53)

Cluster 1
657(79.44)
21.15(6.59)
653(99.39)
526(80.06)
599(91.17)
617(93.91)
574(87.37)
611(93.00)
444(67.58)
600(91.32)
610(92.85)
505(76.86)

114.34
212.67
260.89
141.76

187.13

0.58
65.48
134.40
78.05
245.63
201.13

χ2 (df )

Table 2.4.2: Clinical Opioid-related Characteristics of opioid user clusters [N(%)]

< 1 × 10−16
< 1 × 10−16
< 1 × 10−16
< 1 × 10−16

< 1 × 10−16

0.45
5.55 × 10−16
< 1 × 10−16
< 1 × 10−16
< 1 × 10−16
< 1 × 10−16

p-value
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Table 2.4.3: Risk factors (SNPs) associated with opioid-use subtypes

Cluster 1

Cluster 2

SNP
rs915906
rs10896065
rs7940700
rs755203
rs2581206
rs698
rs4077851
rs2515642
rs6957496

p-value
5.32 × 10−5
3.32 × 10−4
4.15 × 10−4
5.18 × 10−4
5.56 × 10−4
5.59 × 10−4
7.69 × 10−4
8.02 × 10−4
1.09 × 10−5

Odds Ratio
0.6595
2.0537
2.2496
0.7617
0.7594
0.7615
1.5542
0.7294
2.25

Gene
CYP2E1
FOSL1
FOSL1
CHRNA4
SLC6A11
ADH1C
GABRB2
CYP2E1
CHRM2

the two clusters differ significantly on almost all of these clinical features, except the
mean age of first opioid use. Subjects in Cluster 1 have used opioids more heavily than
those in Cluster 2. For example, they had heavier daily use and more intravenous
injections. The negative consequences of opioid use, such as “interfering with work”
and “been arrested” among subjects in Cluster 1 were much more severe than those
for subjects in Cluster 2. Thus, Cluster 1 was a heavy opioid user group whereas
Cluster 2 was composed of moderate opioid users.

Associated Genetic Markers
Eight SNPs were associated with Cluster 1 at p < 1 × 10−3 as shown in Table 2.4.3.
A SNP (rs915906) was very close to the empirical threshold (p < 0.05/1154 = 4.34 ×
10−5 ) after Bonferroni correction was applied to address the inflation of type I error
due to multiple tests. For Cluster 2, SNP rs6957496 on gene CHRM2 was significant
with a p-value close to 10−5 , and it remained significant after Bonferroni correction
(empirical threshold: p < 0.05/1154 = 4.34 × 10−5 ). Odds ratios and the genes where
the corresponding SNPs are located are also shown in Table 2.4.3.
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Table 2.4.4: Comparison on genetic separability of opioid user clusters

Cluster 1
Cluster 2

Optimal σ = 5.8
N(%)
AUC
657(79.4)
0.59
170(20.6)
0.85

σ = 6.07
N(%)
AUC
600(72.6) 0.50
227(27.4) 0.80

Comparison
For the sequential method, we followed the standard approach to selecting σ for
spectral clustering [48] and computed the median value of the pairwise distances,
which was 1.07. When σ = 1.07, a very unbalanced partition was resulted: 826 in
one cluster and 1 in the other, which was not of practical value. In order to find a σ
value that gives clusters of similar size, we increased the value of σ several times, and
each time by 1 until a proper σ was found. The final value was 6.07. Two clusters
were built to separate each subtype from controls. The AUC results were compared to
evaluate the cluster separability in the genetic view as shown in Table 2.4.4. Genetic
markers had better predictive power for those clusters obtained by the proposed
approach than the sequential method with a larger supporting sample size. More
significant associations were found for the clusters created by the proposed method.
Thus it demonstrates the effectiveness of the proposed method.

2.4.4

Cocaine use subtypes

Since a large number of cases were available, we set the desired number of clusters to
3. The optimal value of σ found by our approach here was 1.76.

Age of first cocaine use [Mean (SD) in year]
Age of onset of heaviest cocaine use [Mean (SD) in year]
Used cocaine daily or almost daily
Injected cocaine intravenously
Stayed high from cocaine for a whole day or more
Strong desire for cocaine made it hard to think of
anything else
Cocaine interfered with work, school, or home life
Family members, friends, doctor, clergy, boss, or
people at work or school objected to cocaine use
Been arrested or had trouble with the police because
of cocaine use
Give up or greatly reduced important activities due
to cocaine use
Ever treated for an cocaine-related problem
Ever attended self-help group for cocaine use

Behaviors

Cluster 2
328(31.94)
19.53(5.16)
25.82(8.12)
251(76.52)
132(40.24)
210(64.02)
176(53.66)
139(42.38)
173(52.74)
69(21.04)
179(54.57)
91(27.74)
89(27.13)

Cluster 1
340(33.11)
17.61(4.13)
25.95(8.09)
329(96.76)
311(91.47)
304(89.41)
308(90.59)
312(91.76)
310(91.18)
223(65.59)
321(94.41)
264(77.65)
250(73.53)

249(69.36)
227(63.23)

340(94.71)

175(48.75)

311(86.63)
324(90.25)

Cluster 3
359(34.96)
21.28(6.22)
29.47(7.70)
340(94.71)
33(9.19)
327(91.09)
332(92.48)

178.74(2)
139.27(2)

177.31(2)

127.35(2)

198.06(2)
159.72(2)

79.50(2)
44.48(2)
73.32(2)
298.77(2)
83.49(2)
162.45(2)

χ2 (df )

Table 2.4.5: Clinical cocaine-related Characteristics of cocaine user clusters [N(%)]

< 1 × 10−16
< 1 × 10−16

< 1 × 10−16

< 1 × 10−16

< 1 × 10−16
< 1 × 10−16

< 1 × 10−16
2.19 × 10−10
1.11 × 10−16
< 1 × 10−16
< 1 × 10−16
< 1 × 10−16

p-value
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Cluster Clinical Characteristics
The three clusters obtained with σ = 1.76 were characterized in Table 2.4.5 based on
12 important features related to cocaine use and its consequences. Table 2.4.5 shows
that the three clusters differ significantly on all the 12 clinical features. Both Clusters
1 and 3 were heavy cocaine user groups compared to Cluster 2 as indicated by almost
all of the features. For example, 96.76% and 94.71% of the subjects in Clusters 1
and 3, respectively, ever used cocaine daily or almost daily in comparison with only
76.52% of the subjects in Cluster 2. Even though Clusters 1 and 3 were both heavy
user groups, they were distinct on several features, especially on the age of onset and
on cocaine intravenous injection rates. Subjects in Cluster 1 started the initial and
heavy use of cocaine at much younger age than those in Cluster 3. Cluster 1 had a
high portion of subjects (91.47%) who had injected cocaine intravenously in contrast
to a much lower rate of that (9.19%) in Cluster 3.

Associated Genetic Markers
The results from association tests for the three clusters are provided in Table 2.4.6,
in which only those SNPs with tested p values less than 1 × 10−3 are shown. SNP
rs3802280 on gene OPRK1 was associated with Cluster 1 at p < 1 × 10−3 . Four SNPs
were identified to be nominally associated with Cluster 3 at p < 1 × 10−3 . None of
the SNPs was identified to be associated with Cluster 2 at p < 1 × 10−3 .

Comparison
For the CD data, the median value of the pairwise distances was 1.45, which was
used as the value of σ in the sequential method. We ran spectral clustering based
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Table 2.4.6: Risk factors (SNPs) associated with cocaine-use subtypes
Cluster 1
Cluster 3

SNP
rs3802280
rs511895
rs722651
rs7940700
rs494024

p-value
7.98 × 10−4
3.03 × 10−4
4.95 × 10−4
5.87 × 10−4
6.22 × 10−4

Odds Ratio
1.8265
0.6456
1.5062
0.6585
0.6602

Gene
OPRK1
CAT
MPDZ
CAT
CAT

on the similarity matrix and also obtained three clusters. We compared these three
clusters against those obtained by our approach in terms of the cluster separability
based on genetic data. We built three classifiers, each used to separate subjects in one
cluster from the controls. We averaged the AUC of the three classifiers with standard
deviation over the 10-fold cross validation. A box plot was drawn for each method
as shown in Figure 2.4.1. As shown in Figure 2.4.1, classifiers trained on the clusters
obtained by the proposed method have a slightly better average AUC value (i.e.,
separability) and significantly smaller error bar than those obtained on the clusters
from the sequential method, which implicates that the proposed approach is better
in terms of finding genetically-separable clinical clusters than the existing approach.

2.5

Summary

Identifying genes that contribute to risk of complex diseases has been challenging due
to two major issues: (1) The diseases have diverse clinical manifestations and complex
etiology with both genetic and environmental risk factors. (2) Disease phenotypes
are heterogeneous and homogeneous subtypes have not been optimized empirically.
To address these issues, researchers have sought to leverage the technology of cluster
analysis to identify clinically homogeneous subtypes that correlate to homogeneous
genetic risk factors. Although encouraging results have been obtained, success re-
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Figure 2.4.1: The comparison of genetic separability of the cocaine user clusters
obtained by the proposed method and the sequential method in [15].

mains limited because existing methods mismatch the clinical cluster analysis to the
goal of genetic association.
We have developed a novel multi-objective programming approach that optimizes
two objectives: (1) the cluster-derived subtypes should differ significantly in clinical
features; (2) the subtypes can be classified using genetic markers. Our method forms
a novel multi-view data analytic method that treats the different views differently
instead of equally as input views. In our method, the view of clinical features was
used to define and derive subtypes of the disease based on cluster analysis, and the
view of genetic markers was used to interpret the subtypes based on sparse modeling.
Two case studies of subtyping of opioid use and cocaine use, and related behaviors
in aggregated samples of European Americans were performed. A comparison be-
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tween our proposed approach and a typical subtyping method [15] demonstrated the
superiority of our approach.

Chapter 3
Multi-view Singular Value
Decomposition for Disease
Subtyping and Genetic
Associations

3.1

Introduction

Integration of data from the phenotypic and genomic dimensions offers benefits such as
new opportunities to find confirming evidence of a subtype from its genetic basis and
phenotypic manifestations. A few studies examined the joint use of gene expression
and genotype data for cancer subtyping [17, 69], but they did not identify the variable
subspaces in the two sources of data to group subjects into consistent clusters across
the two subspaces. Hence, they cannot detect genetic variants that are associated
with the identified clusters.
There has been little research on this topic in the statistics literature. The most
32
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related area involves co-clustering [43] or multi-view data analysis [16], where samples
are characterized or viewed in multiple ways, thus creating multiple sets of input
variables. There are two types of co-clustering methods: (1) biclustering, also called
two-mode clustering [72, 46], which simultaneously clusters the rows and columns of
a data matrix and (2) multi-view co-clustering [42, 43] which seeks groupings that are
consistent across different views. Biclustering is similar to another set of algorithms
[29] that search for subspaces and group subjects differently in each subspace.
Biclustering and subspace searching essentially find different subgroups of subjects
using different features (or markers), thus helping to identify genetic variants specific
to a particular subgroup. However, it can only be applied to one data matrix from
a single view rather than data jointly from more views. Multi-view co-clustering,
on the other hand, seeks a grouping of subjects that is consistent across different
views (i.e., different sets of features), but resultant clusters are defined using all given
features. Hence, it cannot be used to identify subtype-specific variants/features. Our
subtyping problem seeks a grouping of subjects that is consistent when using clinical
features and using genetic markers, but also requires a subspace search to identify
the specific features or markers that define the subgroups.
In this chapter, we propose a multi-view matrix decomposition approach based
on the sparse singular value decomposition (SSVD) technique [46] to classify a complex disease into subtypes using data both from the clinical and genetic views. The
objective of this problem is to identify subject clusters that agree in the clinical and
genetic views, and simultaneously identify features and markers that are associated
with the clusters. Employing the SSVD in our approach is critical to its success,
especially in terms of successfully detecting associative variants given the number
of true associative variants are much fewer than the single nucleotide polymorphisms
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(SNPs) in the whole genome. The proposed approach has been validated on synthetic
datasets that are simulated to have subtype structures and several genetic markers
associated with the subtypes and a real world clinical dataset that is aggregated from
multiple genetic studies of cocaine dependence. We compared our approach to the
biclustering approach in [46] and the latest multi-view data analytics methods [43].
The results clearly shows the superior performance of our approach over all other
compared methods.

3.2

Methods

We start with a presentation of the notations that are used throughout the chapter.
A vector is denoted by a bold lower case letter as in v and kvkp represents its `p -norm
that is defined by kvkp = (|v(1) |p +· · ·+|v(d) |p )1/p , where v(j) is the j-th component of
v and d is the length of v, i.e., the total number of components in v. We use kvk0 to
represent the so-called 0-norm of v that equals the number of non-zero components
in v. Denote u

v the component-wise (Hadamard) products of u and v. The set

Bd contains all binary vectors of length d. A binary vector is a vector of components
that equal either 0 or 1. A matrix is denoted by a bold upper case letter, e.g., Mn×d
is a n-by-d matrix, and kMkF is its Frobenius norm defined by (tr(MT M))1/2 where
tr(·) is the trace of a matrix. Rows and columns in M are noted by M(i,·) and M(·,j) ,
respectively.
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3.2.1

Review of single-view biclustering

We briefly review the biclustering method with a single view of data based on the
sparse singular value decomposition [46]. For a single data matrix M of size n-by-d, a
subgroup of its rows and a subgroup of its columns can be simultaneously obtained by
the SSVD. The SSVD requires both the left and right singular vectors to be sparse.
Let u of size n and v of size d be a pair of singular vectors resulted from the SSVD.
Their outer product forms a sparse low-rank approximation of the original matrix,
i.e., M = σuvT where σ is the corresponding singular value. Then, the rows in M
corresponding to non-zero components in u form a row subgroup. The columns in M
corresponding to non-zero components in v form a column subgroup. The resulted
row and column clusters help to define each other. The SSVD finds all singular vectors
sequentially by repeatedly solving the following problem with a data matrix M:
min

σ,u,v

subject to

kM − σuvT k2F + λu kσuk0 + λv kσvk0
(3.2.1)
kuk2 = 1, kvk2 = 1.

The regularization terms kσuk0 and kσvk0 are used to enforce the sparsity of u and
v. Notice that the scalar σ will not affect the value of the regularization terms. The
parameters λu and λv are two hyper-parameters to balance between the approximation
performance and the regularization terms. If both λu and λv equal 0, the optimal
solution to this problem is the left and right singular vectors of M that correspond to
its largest singular value. An alternating algorithm has been proposed in [46] to solve
this problem effectively when λu and λv are not 0. This algorithm first initiates u and
v by the first left and right singular vectors of M, then alternates between solving
two sub-problems until it converges. The two sub-problems are: (a), fix u and find
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v that optimizes the objective of Eq.(3.2.1); (b), fix v and find u that optimizes the
objective of Eq.(3.2.1).
Assume that the rows and columns of M represent subjects and their features,
respectively. Once a pair of vectors u and v is obtained, a subject (row) cluster
as indicated by the non-zero components of u is obtained. At the same time, the
features on which the subjects in the cluster show high similarity are also identified
in a column cluster as indicated by the non-zero components of v. More clusters
can be obtained by repeating the optimization process with modified data matrices.
To obtain subsequent clusters that do not overlap with subjects in any identified
cluster, the SSVD solves Eq.(3.2.1) using a new matrix M̃ which excludes subjects
(rows) already included in a row cluster. To obtain subsequent clusters that allow
overlapping of subjects with identified clusters, the SSVD can solve Eq.(3.2.1) with
the deflated M̃ = M − σuvT as used in the standard SVD.

3.2.2

The proposed formula for two-view joint biclustering

In this section, we extend the single-view SSVD to find consistent grouping of subjects
across two data matrices. The resulting method will be extended to incorporate more
than two data matrices in a later section.
Assume that two data matrices denoted by M1 of size n-by-d1 and M2 of size nby-d2 characterize the same set of n subjects from two different views. We can obtain
u1 , v1 , and u2 , v2 by a separate SSVD of M1 and M2 , respectively. However, it
will not guarantee that the row clusters specified by u1 and u2 agree. To make them
consistent, it requires u1 and u2 to have non-zero components at the same position.
Notice that the two u vectors are not necessarily the same given they may be derived
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from very different features in the views, such as real-valued clinical features but
discrete values in genetic markers.
We propose to use a binary vector z of size n that serves as a common factor to
link the two views. Each component of u is then multiplied by the corresponding
component of z, i.e., ui = ui zi . In other words, we represent each u vector by z

u

in the objective function of SSVD to construct the sparse, rank one approximation
matrices of M1 and M2 , simultaneously. When z is sparse, both z

u1 and z

u2

will be sparse. Thus, we enforce the sparsity of z rather than individual u and solve
the following optimization problem:
min

z,σi ,ui ,vi ,i=1,2

kM1 − σ1 (z

u1 )vT1 k2F + kM2 − σ2 (z

u2 )vT2 k2F

+ λz kzk0 + λv1 kσ1 v1 k0 + λv2 kσ2 v2 k0 ,
subject to

kui k2 = 1, kvi k2 = 1,

(3.2.2)

i = 1, 2,

z ∈ Bn .
where λz , λv1 and λv2 are tuning parameters that balance the approximation errors
and regularization terms. Although the u’s are constrained to be unit vectors, the
z

u’s are not necessarily unit vectors. However, a careful examination reveals that

for any optimal solution û, we can find another optimal solution ū that has only
non-zero values at the entries indicated by the binary vector z, which ensures that
z

ū is also a unit vector. We first set ū(j) = û(j) , if z(j) 6= 0, or ū(j) = 0 otherwise,

for j = 1 · · · , n. Then, we update the corresponding singular value σ = σkūk2 and
rescale ū = ū/kūk2 . This new vector ū together with the new σ will produce the
same objective value as the original solution û, and hence is an optimal solution as
well. We will design a fast algorithm to find such a ū for Eq.(3.2.2).
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We discuss two alternatives to the proposed formula (3.2.2). A restricted version
of Eq.(3.2.2) may require u1 = u2 = u and then replace z

u1 and z

u2 by the

same u in the objective function of Eq.(3.2.2), which leads to the following problem
kM1 − σ1 uvT1 k2F + kM2 − σ2 uvT2 k2F

min

σi ,u,vi ,i=1,2

+ λu kuk0 + λv1 kσ1 v1 k0 + λv2 kσ2 v2 k0 ,
subject to

kuk2 = 1, kvi k2 = 1,

(3.2.3)

i = 1, 2.

By requiring u to be sparse, it can also identify consistent row clusters between two
views. The resultant optimization problem is easier to solve without integer variables
in z. However, it is an unnecessary stringent constraint to limit the search space to
u1 = u2 , which rules out a number of potential solutions that may include the optimal
row clusters. Another alternative is to minimize the difference between u1 and u2 ,
which suffers from the same over-constrained problem because the exact values of the
difference are not concerned. Our problem only seeks the indicators of whether or
not a component of u is zero.
It is insightful to also discuss the relation between Eq.(3.2.3) and the feature
concatenation method which simply merges the features from the two views in a
cluster analysis. The feature concatenation method finds a single set of u and v for
the data matrix [M1 M2 ] by solving the following problem
min

σ,u,v

subject to

k[M1 M2 ] − σuvT k2F + λu kσuk0 + λv kσvk0
(3.2.4)
kuk2 = 1, kvk2 = 1.

where the v vector is of size d1 + d2 . In comparison with Eq.(3.2.3), Eq.(3.2.4) uses a
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single σ for the two views, and the concatenated v is constrained to be a unit vector
rather than individual v1 and v2 . It is easy to show that any optimal solution to
Eq.(3.2.3) can be feasible to Eq.(3.2.4) by properly rescaling v1 and v2 and absorbing
the scaling factors by σ1 and σ2 to make σ1 = σ2 , but is unnecessarily an optimal
solution to Eq.(3.2.4). An optimal v to Eq.(3.2.4) may have either v1 or v2 be zero,
which is however not allowed in Eq.(3.2.3). When one of the v’s is zero, the resultant
clusters differ only on one view of the features. As an example, we concatenated 64
clinical features to 1248 SNPs in a disease subtyping analysis. Because the number
of genetic markers outweighed that of clinical features, the resultant clusters differed
significantly on the SNPs only, leading to disease subtypes that cannot be clinically
recognized.

3.2.3

A fast algorithm for two-view joint biclustering

The proposed formulation (3.2.2), although is a mixed-integer program, can be effectively solved after proper relaxations. We design an alternating optimization algorithm to solve it by splitting the variables into three working sets: one set consists
of u’s; one set consists of v’s; and the last set consists of the binary variables z. We
optimize the variables in one working set at a time in alternative steps.
(1) Find the optimal u1 , v1 , u2 , and v2 with fixed z
When z is fixed, Problem (3.2.2) can be decomposed into two sub-problems that
optimize with respect to each individual view. Without loss of generality, we show
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how to optimize u1 and v1 by solving the following sub-problem with a fixed z.
min

σ1 ,u1 ,v1

subject to

kM1 − σ1 (z

u1 )vT1 k2F + λv1 kσ1 v1 k0
(3.2.5)

ku1 k2 = 1, kv1 k2 = 1,

which can be solved by alternating between optimizing for u and for v.
(a) Solve for v1 when u1 is fixed
We solve the following equivalent problem for the optimal ṽ1 by relaxing the unit
length constraint on v1 , and then setting σ1 = kṽ1 k2 and v1 = ṽ1 /σ1 .

min
ṽ1

kM1 − (z

u1 )ṽT1 k2F + λv1 kṽ1 k0 .

(3.2.6)

Similar to the single-view SSVD, we relax the 0-norm to have the `1 vector norm,
and solve for v by minimizing kM1 − (z

u1 )ṽT1 k2F + λv1 kṽ1 k1 . Each component ṽ1(j)

in ṽ1 can be computed independently from the others by solving

min
ṽ1(j)

ṽ21(j) − 2α(j) ṽ1(j) + 2β|ṽ1,(j) |,

where α(j) = uT1 M1(·,j) , and β = λv1 /2. This problem can be solved analytically by
soft-thresholding [46]:

ṽ1(j)




α(j) − β,




=
0,





α(j) + β,

(b) Solve for u1 when v1 is fixed

if α(j) > β,
if |α(j) | ≤ β,
if α(j) < −β,

j = 1, · · · , d.

(3.2.7)
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After v1 is obtained and fixed, we optimize Problem (3.2.5) with respect to σ1
and u1 . We let ũ1 = σ1 u1 , and solve the following problem to obtain ũ1 . By setting
σ1 = kũ1 k2 and u1 = ũ1 /σ1 , we obtain a solution to Problem (3.2.5).

min
ũ1

kM1 − (z

ũ1 )vT1 k2F .

(3.2.8)

Each component u1(i) in an optimal u1 can be independently and analytically computed as follows:

ũ1(i)


M1(i,·) v1


,

z(i)
=



0,

if z(i) 6= 0
i = 1, · · · , n.

(3.2.9)

if z(i) = 0.

(2) Find the optimal z with fixed u1 , v1 , u2 , and v2
When all u’s and v’s are fixed in Problem (3.2.2), the optimization problem becomes:

min

z∈Bn ,σ1 ,σ2

kM1 − σ1 (z

u1 )vT1 k2F + kM2 − σ2 (z

u2 )vT2 k2F + λz kzk0 .

(3.2.10)

Denote the values of σi ’s from the previous iteration by σ̂1 and σ̂2 . We temporarily
relax the binary z variables to be real-valued and then let z̃ = σ̂1 z. Again, we use
the `1 -norm of z̃ to approximate its 0-norm and solve the following problem for z̃:

min kM1 − (z̃
z̃

u1 )vT1 k2F + kM2 − (σ̂2 /σ̂1 )(z̃

u2 )vT2 k2F + λz kz̃k1

(3.2.11)

The normalization step for z̃ by σ1 is used to contrast the different singular values
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for the different views so re-scaling z will not cause an issue. Notice that Problem
(3.2.11) can be rewritten into the following problem

min kM − diag(z̃)Ek2F + λz kz̃k1
z̃

where M = [M1 M2 ] is obtained by concatenating the data matrices in columns,
E = [u1 vT1 (σ̂2 /σ̂1 )u2 vT2 ], and diag(z̃) converts z̃ into a diagonal matrix. Then, each
component of an optimal z̃ can be analytically computed as follows:

z̃(i)

where γ(i) =

E(i,·) MT
(i,·)
kE(i,·) k22




γ(i) − θ,




=
0,





γ(i) + θ,

and θ =

γ(i) > θ
i = 1, · · · , n.

|γ(i) | ≤ θ

(3.2.12)

γ(i) < −θ

λz
.
2kE(i,·) k22

Eq.(3.2.12) is derived based on the same

calculation in [46] as how Eq.(3.2.7) is derived.
After obtaining z̃, the solution z to Problem (3.2.10) can be calculated as follows:

z(i) =



1,

if z̃(i) 6= 0


0,

if z̃(i) = 0.

i = 1, · · · , n.

(3.2.13)

To preserve the same objective value of Problem (3.2.2) after updating z, we
update u1 and u2 accordingly as follows:

u(i) =



u(i) /z̃(i) ,

if z̃(i) 6= 0,

0,

if z̃(i) = 0,




i = 1, · · · , n.

(3.2.14)
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and σ1 , σ2 are recalculated as: σ1 = ku1 k2 , σ2 = (σ̂2 /σ̂1 )ku2 k2 , then we normalize u1
and u2 by u1 = u1 /ku1 k2 , and u2 = u2 /ku2 k2 .
The proposed algorithm alternates between solving the three sub-problems (3.2.6),
(3.2.8) and (3.2.10) until a local minimizer is reached. The overall objective is monotonically non-increasing when minimizing each sub-problem, so the convergence of
this iterative process is guaranteed. In our experiment both on synthetic and real
world datasets, this process reached a convergent point in about 10 iterations. To
derive another row subgroup, we repeat the algorithm using new matrices M1 and
M2 that either exclude the rows corresponding to the subjects in the identified subgroup or are deflated by subtracting the identified singular value components σuvT .
By repeating this procedure, the desired number of subject groups can be achieved.

3.2.4

Extension to more than two views

In some applications, more than two views of data can be available. For example,
besides data on clinical features and genetic markers, gene expression data may also
be used in an analysis. The optimization problem (3.2.2) can be readily extended to
incorporate m separate data matrices, e.g., Mi , i = 1, ·, m, as follows:

min

z,σi ,ui ,vi ,i=1,...,m

subject to

m
X

kMi − σi (z

ui )vTi k2F + λz kzk0 +

i=1

kui k2 = 1, kvi k2 = 1,

m
X

λvi kσi vi k0 ,

i=1

i = 1, ..., m,

z ∈ Bn .
This problem can be similarly solved by decomposing it into several sub-problems
and alternatively solving each sub-problem. We obtain the singular vectors of the
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data matrix in the view i, i.e., ui and vi while fixing z and other u’s and v’s by
optimizing:
min

σi ,ui ,vi

subject to

kMi − σi (z

ui )vTi k2F + λvi kσi vi k0 ,

kui k2 = 1, kvi k2 = 1.

Notice that when z is fixed, the optimization of ui and vi is independent from each
other among different views. Thus, these singular vectors can be computed in parallel,
which can bring down the computation time significantly when more computational
resources are available. When ui and vi are fixed for all views, we solve the following
problem to obtain z̃ and rescale z̃ to obtain z.

min
z̃

m
X

kMi − (σ̂i /σ̂1 )(z̃

ui )vTi k2F + λz kz̃k1 .

i=1

Algorithm 2 summarizes all the related steps to solve a multi-view SVD. Again, this
algorithm can be repeated to obtain subsequent clusters in iterations. Although a
good initialization can be problem-specific, we choose to initialize z with a vector of
all ones which assumes that all subjects have potentials to be in the cluster if no prior
is given.

3.3

Computational Results and Discussion

We first validated the proposed method using synthetic data that was simulated with
known cluster and association structures. Then we evaluated our approach on a real
world disease dataset aggregated from multiple genetic studies of cocaine dependence
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Algorithm 2 Multi-view Singular Value Decomposition
Input: Mi , λz , λvi , i = 1, · · · , m
Output: z, σi , ui , vi , i = 1, · · · , m
1. Initialize z with a vector of all ones.
2. Initialize ui ’s by the corresponding left singular vectors of Mi , i = 1, · · · , m.
3. For i = 1, · · · , m,
Compute ṽi by Eq.(3.2.7).
Compute vi from ṽi and update σi .
Compute ũi by Eq.(3.2.9).
Compute ui from ũi and update σi .
4. Compute z̃ by Eq.(3.2.12).
5. Compute z from z̃ by Eq.(3.2.13).
6. Update σi , ui , i = 1, · · · , m by Eq.(3.2.14) accordingly.
Repeat Steps 3 to 6 until z reaches a fixed point.
(CD).
Normalized mutual information (NMI) was used to measure the consistency between two cluster solutions. Denote two clusterings by C (1) and C (2) where each
clustering contains a number of clusters as a partition of a given sample, and Ci indexes the subjects in the i-th cluster. NMI computes the mutual information between
the two clusterings normalized by the cluster entropies. In other words,

NMI(C

(1)

(1)

where I(C (1) , C (2) ) =

,C

(2)

(2)

|Ci ∩Cj |
i,j
n

P

I(C (1) , C (2) )
)=
(H(C (1) ) + H(C (2) ))/2
(1)

log

(2)

n|Ci ∩Cj |
(1)
(2)
|Ci ||Cj |

, H(C) = −

(3.3.1)

|Ci |
i n

P

log |Cni | , and |Ci |

denotes the number of subjects in the index set Ci . Since the true clusters are known
in synthetic data, we computed NMI to measure the consistency between the true
cluster assignments and the cluster assignments resulted from cluster analysis. Hence,
a higher NMI value indicates better performance.
In addition to NMI, for each clustering, classifiers were constructed based on
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genetic markers to separate subjects in different clusters. We used the Area Under the
receiver operating characteristic Curve (AUC) [22] in a 10-fold cross validation setting
to measure the genetic separability or homogeneity of the clusters in a clustering and
compared it between different clusterings. We used a regularized logistic regression
[85] as the classification model throughout these experiments.
Extensive comparison of the proposed approach against biclustering and multiview analytics was conducted. We calculated NMI for different methods on synthetic
data and AUC values on both synthetic and real world data. The existing methods
that were used in our comparison study are given in the following list:
• Single-view SSVD: Clusters were included in the comparison by running
the method of SSVD-based biclustering in the clinical view as the biclustering
method does not handle multiple views. Applying this method to genetic data
created completely different clusters from those obtained in the clinical view.
• Co-regularized spectral: This method was proposed in [43] for finding consistent row clusters among multiple views by applying spectral clustering alternatively on each view together with a co-regularization factor applied to the
cluster indicator vector.
• Kernel addition: Radial basis function (RBF) kernels were calculated for
each view and combined by adding them together. Then spectral clustering
was applied to the combined kernel to obtain row clusters.
• Kernel product: This is the same procedure in the kernel addition described
above except that kernel matrices were combined by multiplying their components in the same position.
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• Feature concatenation: Data from the two views were simply put together by
feature concatenation and a kernel matrix was computed based on the combined
dataset and used in spectral clustering to obtain row clusters.

3.3.1

A simulation study

Two disease subtypes, subtype 1 and subtype 2, were simulated. Each of them was
not only defined by a set of phenotypic/clinical features but also associated with a set
of genetic markers. However, the clinical features and genetic markers are different
for the two subtypes. Each subtype hence corresponded to a cluster of subjects that
presented the specific clinical features and had minor alleles at the associated SNP
markers (here we assumed that minor alleles were risk variants). The goal of the
simulation was to create an agreed partition of subjects in both views of their genetic
markers and clinical features.
Genetic data was obtained from the 1000 Genome Project [2] in which 1092 subjects were genotyped with several million genetic markers. We randomly selected 1000
markers from chromosome 5 that had a minor allele frequency (MAF) of at least 5%
as genetic inputs in our experiments. Ten markers (different for each subtype) were
randomly chosen to be associated with each subtype. Thus, a cluster of subjects was
formed for each subtype, and we assigned subjects to a cluster if they had ≥ 8 risk
variants out of the 10 chosen SNPs for that subtype. This amounts to an additive
genetic model for each subtype (i.e., adding up risk variants). Subjects who did not
belong to any of the subtypes were treated as controls, forming the third subject cluster. We removed from the analysis subjects who belonged to both subtypes to ensure
the clarity in the partition. In total, 1013 subjects were retained. Of these, 247 and
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167 were assigned to subtype 1 and subtype 2, respectively and 599 were controls. We
named these clusters the genotypic clusters.
We then created clusters of the same subjects in the clinical view which were
consistent to certain degree with the genotypic clusters. Notice that many diseases,
although highly heritable, are multifactorial both genetically and environmentally.
To reflect the environmental effects on the clinical features, we introduced random
noise to the synthesized clinical data so that the clinical clusters were not exactly the
same as the genotypic clusters, which aimed to test the robustness of the proposed
approach. We used a parameter e to indicate the relative effect that genetic variation
contributed to the phenotypic variation. Denote rij the number of risk variants of
subtype j that subject i had, so 0 ≤ rij ≤ 10 according to our definition of genotypic
clusters. If rij ∗ e + N (0, 1) > 7.5 ∗ e, we assigned subject i to subtype j. This process
created different but very similar clusters of subjects to the genotypic clusters (and
the noise parameter e determined the level of similarity).
We named these clusters the phenotypic clusters because these clusters were used
to synthesize clinical features so that the cluster structure was reflected in the clinical
data. Similarly, we removed from the analysis the subjects that overlapped in the
two phenotypic clusters. Fewer than 15 subjects were excluded in any simulated
dataset in the experiments. In addition to the two phenotypic clusters, two additional
phenotypic clusters, independent of any genetic variant and based on clinical features
only, were created to make the simulated data more realistic. The two additional
clusters each included 200 subjects that were randomly selected from the controls.
This design aimed to reflect the observation that multiple clinical clusters may exist in
a sample, but only some clusters (two in our simulations) are associated with genetic
factors.
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We simulated 10 binary phenotypic/clinical features that exhibited the phenotypic
clusters. A subject was assigned a value of 0 or 1 for each of the features according
to a probability. Subtype 1 and subtype 2 each was associated with three features.
Subjects in each simulated phenotypic cluster obtained the value of 1 with probabilities of 0.6, 0.5, 0.4, respectively for the three designated features. Each of the two
additional phenotypic clusters was associated with two features, and subjects in each
of the two subtypes obtained the value of 1 in the two features, with probabilities of
0.6 and 0.5, respectively. A subject obtained the value of 1 with a probability of 0.1
on any other features.
To evaluate how the proposed method performed when the genetic effect varied,
four phenotypic datasets with e = 1, 0.8, 0.6, and 0.4 were generated and analysed.
The genetic effect on phenotypic variation decreases with decreasing e, which leads
to a lower level of agreement between genotypic and phenotypic clusters.
All of the compared methods were used to obtain three subject clusters. Table
3.3.1 provides the NMI calculated by comparing subject clusters obtained from each
approach to true phenotypic clusters simulated. The proposed method has the greatest NMI on all of the four datasets. Along with the decreasing e, NMI obtained by the
proposed method decreases gradually as expected, but the subject clusters consistent
between the two views can still be uncovered.
For each cluster solution, two classification models were built to separate subjects
in each of the two subtypes from controls. The subject cluster from each method
containing the largest number of controls was considered as the control group. The
average AUC values and their interquantiles obtained by all compared approaches on
each dataset are plotted in Figure 3.3.1. The proposed method achieved the second
best performance on this measurement. Although the feature concatenation method
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Table 3.3.1: Comparison between different approaches on normalized mutual
information (NMI) values. The NMI values for different approaches with different
genotypic effect e to the phenotypic variation in simulated data.
e=1
Single-view SSVD
Co-regularized Spectral
Kernel addition
Kernel product
Feature concatenation
Proposed method

0.0821
0.2306
0.2587
0.1917
0.1569
0.7949

e = 0.8 e = 0.6 e = 0.4
0.1798
0.2477
0.2295
0.2432
0.1576
0.7693

0.2432
0.2338
0.2350
0.2302
0.1532
0.6815

0.2286
0.2549
0.2566
0.2310
0.1211
0.6329

found the clusters that were most separable genetically with the best AUC, these
clusters were not recognizable in clinical features. As shown in Table 3.3.1, they were
most disparate from the simulated true phenotypic clusters.
A significant advantage of the proposed method is that it can simultaneously
identifies the features that specify the subject clusters. We calculated the number
of features that were correctly and incorrectly identified by the proposed method to
measure its performance in this regard. The results are summarized in Table 3.3.2,
which shows that our approach correctly identified all true associated features in both
views with a very low false discovery rate (∼ 15/1000) when taking into account the
total number of features used in the analysis.

3.3.2

A case study: cocaine use and related behaviors

A total of 1474 subjects were phenotyped and genotyped for genetic studies of cocaine dependence [1]. Subjects were recruited from the Yale University School of
Medicine, University of Connecticut Health Center, University of Pennsylvania School
of Medicine, McLean Hospital and Medical University of South Carolina. All sub-
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Figure 3.3.1: Comparison between different approaches in terms of AUC values on
simulated data. The box plot of AUC values obtained from all comparison approaches on
simulated data. A1 - the proposed method, A2 - single-view SSVD, A3 - co-regularized
spectral, A4 - kernel addition, A5 - kernel product, A6 - feature concatenation. e is the
genetic effect to the phenotypic variation in simulated data.

jects gave written, informed consent to participate, using procedures approved by
the institutional review board at each participating site. Subjects were phenotyped
using a computer-assisted interview, called the Semi-Structured Assessment for Drug
Dependence and Alcoholism (SSADDA) [59], a polydiagnostic instrument that was
used to generate diagnoses of cocaine and other substance dependence. Sixty-four
yes-or-no variables were generated by this survey, which were also used in previous
genetic association studies [41, 9]. These variables were used as the phenotypic fea-
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Table 3.3.2: Statistics of features identified by the proposed method for both subgroups
in the two views. e is the genetic effect to the phenotypic variation in simulated data. TF
is the number of True Features that specify a population subgroup. TPF (True Positive
Features) is the number of features correctly identified. FPF (False Positive Features) is
the number of features incorrectly identified.
Phenotypic view

subtype 1

e=1
e = 0.8
e = 0.6
e = 0.4

subtype 2

e=1
e = 0.8
e = 0.6
e = 0.4

TF

TPF

FPF

3

3
3
3
3

1
1
2
0

3

3
3
3
3

0
0
0
0

Genotypic view
TF

TPF

FPF

10

10
10
10
10

4
5
15
10

10

10
10
10
10

4
4
2
5

tures. Of the 1474 subjects, 1287 were diagnosed with cocaine dependence. Subjects
were genotyped with 1350 SNPs that were selected from 130 candidate genes [33];
1248 SNPs with minor allele frequency (MAF) of at least 1% were used as genetic
markers in our analysis.
The feature concatenation method overlooked the information in the clinical or
phenotypic view as observed in both the simulation study and this case study. We
hence excluded the kernel concatenation method from the further comparison. Three
subject clusters were obtained from each of the methods in the comparison. Classification models were built and tested in a manner similar to that used for synthetic
data. Figure 3.3.2 shows the box plot of the AUC values. As shown in Figure 3.3.2,
our approach significantly outperformed all other methods with respect to the genetic
separability of the resultant clusters. A paired t-test was performed to compare the
AUC values from our method with those from a compared method, yielding p-values
< 0.05 for all comparisons.
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Figure 3.3.2: Comparison between different approaches in terms of AUC values on
cocaine data. The box plot of AUC values obtained from all comparison approaches on
dataset of cocaine use and related behaviors. A1 - the proposed method, A2 - single-view
SSVD, A3 - co-regularized spectral, A4 - kernel addition, A5 - kernel product.

For the proposed method, the three identified subject clusters contained 795
(Group 1 ), 295 (Group 2 ) and 384 (Group 3 ) subjects, respectively. Group 1 and
Group 2 were identified consecutively, and Group 3 contained the remaining subjects. Group 3 contained more than 80% of the control subjects. We hence used this
group as a control group in our association analysis. The number of clinical features
identified to be associated with Group 1 and Group 2 were 18 and 17, respectively.
Figures 3.3.3 and 3.3.4 compare the three subject clusters in terms of the percentage
of positive responses to the identified clinical features. A few identified features are
not shown in the figures, because they are highly correlated with the features in the
figures with a correlation coefficient > 0.7.
From these two figures, we can see that Group 1 is distinctively associated with
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Percentage of positive response

1
Felt depressed1
Had trouble concentrating1
Felt depressed2

0.8

Felt restless2
Felt tired2
Had trouble sleeping2
Desire for cocaine2

0.6

Felt slowed down2
Daily functioning was interfered1

0.4

0.2

0

1

2
Patient clusters

3

Figure 3.3.3: Comparison between the three cocaine user subgroups on features linked
to Group 1. 1 indicates symptoms due to cocaine use. 2 denotes symptoms due to
stopping, cutting down or going without cocaine.

several withdraw symptoms, such as felt depressed, restless, or tired when the subject
stopped, cut down or went without cocaine. When Group 2, the second row cluster,
was identified, the corresponding column cluster contained 17 clinical features. We
plotted the percentage of positive responses to eight of these features for all three
cocaine user groups in Figure 3.3.4. Besides the subjects in Group 2, the subjects in
Group 1 also showed high values on these features. Note that these subjects were
already excluded when the second cluster was derived. From these observations, we
can conclude that Group 1 is a heavy user group with many negative consequences of
cocaine use, Group 2 is a moderate cocaine user group, and Group 3 is a low cocaine
user group.
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Percentage of positive response

1

Often used on more days or in larger amount
Spent a great deal of time with cocaine
Stayed high for a whole day or more
Had a paranoid experience
Decreased contact with friends or family
Could not stop or cut down on cocaine
Objection from others because of cocaine use
Being treated for a problem with cocaine

0.8

0.6

0.4

0.2

0

1

2
Patient clusters

3

Figure 3.3.4: Comparison between the three cocaine user subgroups on features linked
to Group 2.

There were 114 and 237 genetic markers identified for Group 1 and Group 2
respectively. Two classification models were built to further identify the top markers
that had the highest predictive power in separating subjects in Group 1 or in Group
2, from those in the control group. Table 3.3.3 gives the top 5 SNPs that showed the
highest influence in terms of distinguishing the case groups from the control group.
It is also interesting to point out that the HTR2C gene significantly associated with
Group 1 in our study (with a p-value < 10−5 ) was previously identified for a heavy
use, early-onset and high comorbidity subtype of cocaine dependence [9].
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Table 3.3.3: Top five SNPs with the largest magnitude of weights in the two
classification models. These two models are built to separates controls in Group 3 from
cases in Group 1 and Group 2, respectively.
SNP

3.4

Chr

MAF

HWE

Gene

Group 1
VS
Group 3

rs6318
rs2427400
rs460401
rs10485058
rs2279423

chrX
chr20
chr21
chr06
chr15

0.3643
0.1280
0.3500
0.0585
0.0237

1.00
0.22
0.18
0.38
0.81

HTR2C
NTSR1
GRIK1
OPRM1
CHRM5

Group 2
VS
Group 3

rs897692
rs9996854
rs481036
rs6092933
rs9371781

chr11
chr04
chr01
chr20
chr06

0.3972
0.5436
0.5582
0.2070
0.3687

0.86
0.61
0.21
0.17
0.49

HTR3A
GABRB1
CHRM3
SLC32A1
OPRM1

Summary

It is challenging to uncover the genetic causes of complex disorders such as substance
dependence, due to the heterogeneity in their clinical manifestation, genetic causes,
and environmental/genetic interactions. Phenotype refinement that leads to homogeneous subtypes has been shown to be a promising approach to solve this problem
[24, 41, 15, 66, 67]. However, most of the methods used for phenotype refinement
take into consideration only the phenotypic information even though genotypic information is usually available in genetic studies of a complex disorder. Thus, these
approaches have limited success in finding a phenotypic subtype that is also genetically homogeneous. In this chapter, we have proposed a multi-view biclustering
approach to perform the phenotype refinement by jointly taking into account genetic
and phenotypic information.
The proposed method is distinct from existing multi-view data analytics in that
the relevant features can be identified at the same time when a subtype is determined,
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which is critical to its success. Hence, associative genetic variants are likely to be
revealed. The proposed method is distinct from existing biclustering methods in that
it harmonizes the subject groupings in two or more views. The developed algorithm
is highly scalable with large datasets because at each iteration it calculates closedform solutions for different groups of working variables. The results from extensive
experimental comparisons on both synthetic data and real world datasets demonstrate
the effectiveness and superior performance of the proposed approach.
This study has a number of limitations. The proposed multi-view biclustering
method, in its current form, does not simultaneously handle population stratification
and phenotype-genotype association. Hence, it may identify markers that are relevant
to a disease subtype only due to population structure rather than the specific disease,
causing spurious association findings. Racial populations are often stratified before an
association analysis is performed. Our method will need to be extended to deal with
the three-way relationship among population subgroups, genotypes and phentoypes in
order to further improve the phenotype-genotype associations. Further, the proposed
method has been used in our empirical study to identify the first two major subgroups
of data, for which we have not observed any invalid clusters caused by random noise.
When more subsequent clusters are to identified, the two methods we have designed
either by excluding subjects in the identified subgroups or by deflating singular value
components from the data matrix both suffer a higher risk to detect invalid clusters
because singular values will decrease in subsequent decomposition. More empirical
studies may be needed to thoroughly examine the signal-to-noise pattern for the
proposed method.

Chapter 4
Identifying Heritable Composite
Traits with Pedigree for Complex
Phenotypes

4.1

Introduction

Complex phenotypes consist of a variety of low level traits that are often highly
variable. Association analysis of such a complex phenotype is impeded by this phenotypic heterogeneity [28]. For example, the diagnosis of drug dependence, such as
dependence on cocaine or opioids, is determined by various patterns of drug use, their
effects, and related behaviors, including the age of first drug use, drug use frequency,
negative consequences of drug use, withdrawal symptoms, and treatment history [59].
A binary composite trait defined based on the low level traits, such as the diagnosis of cocaine dependence, which partitions the population into cases (subjects with
the disease) and controls (subjects without the disease), cannot differentiate the het-
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erogeneous manifestations of the disease. Because of this, the success of identifying
underlying genetic variants in the association study using this binary trait as respondent variable [77, 25]. Identifying highly heritable composite traits or subphenotypes
of the disease could permit the detection of genetic variants that are not detectable
using the standard diagnosis-based traits [36, 9]. Examination of multiple low-level
traits that characterize a complex phenotype has shown the potential to discover
composite traits of high heritability [41, 15, 66]. Efforts have been made to enhance
the binary trait by capturing more phenotypic variation, such as defining a composite trait as symptom count [25]. However, this kind of composite trait can have low
heritability and may thus be sub-optimal for association analysis.
Besides enhancing association analysis as discussed above, identified high heritable composite traits can be of direct use in animal and plant breeding. In agricultural
science, breeding programs targeted at conceptual but economically important phenotypes, such as feed efficiency or heat tolerance, are confronted with a wide variety
of available measures for the phenotype [18, 12]. Residual body weight gain, residual
feed intake and relative growth rate are all feed efficiency measures for dairy cattle
with heritabilities that range from 0.28 to 0.45 [7, 18]. Moreover, each of these measures forms a composite trait that is defined by a linear function of low-level traits,
such as body weight, diet and feed energy intake, and days in milk. Identifying
more heritable measures for conceptual phenotypes could enhance animal and plant
breeding.
Recently, there are methods being proposed in the literature to directly target at
high heritable composite traits by identifying optimal linear combinations of low-level
traits [55, 78, 40, 56]. All current methods decompose the identification of heritable
composite traits into solving two separate subproblems in sequence. They first esti-
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mates two covariance matrices of the low-level traits: Σa , the variance due to additive
genetic effects; and Σ, the covariance matrix due to effects other than additive genetic
effects. If there are d low level traits in x, this means that two d-by-d matrices need
to be estimated from the sample. Once the two covariance matrices are computed,
a generalized eigenproblem is solved to identify the combination coefficients w so
that the ratio of w> Σa w/w> Σw is maximized, leading to high heritability for the
composite trait w> x.
A few methods have been developed in the literature to estimate the two covariance matrices. In [78, 40], the two matrices are estimated based on the genetic effect
of a single quantitative-trait locus to all the low level traits. This method has limited
utility when the variance-covariance of the low level traits is due to multiple genetic
loci (which is often the case for complex phenotypes). In [55, 56, 38], the two covariance matrices are estimated from family pedigrees of the sample. The approach used
in [55] takes only siblings in a family, so it is inadequate to handle general (complex)
pedigrees. The two approaches in [56] and [38] can handle general pedigrees. The
first one derives an analytic formula for the covariance matrices based on Analysis of
Variance (ANOVA). Although reducing the computational cost, the analytic formula
makes it unable to take into account the fixed effects from covariates such as sex, age
or race, which is also a problem for the method in [55]. Currently, the most comprehensive approach is a maximum likelihood method [38] that can estimate the fixed
effects and covariance matrices together, but this method is computationally prohibitive as discussed in [56]. Even when d = 20 low level traits are used, this method
can run hours to report performance and further as observed in our experiments,
the method may not converge even with a large limit on the number of iterations.
Moreover, it requires very large sample set in order to obtain reliable estimates of two
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covariance matrices and d combination coefficients, totally 2d2 + d parameters, from
a sample set.
By solving the inverse problem of heritability estimation, we show that, to obtain
highly heritable multivariate traits, the estimation of two covariance matrices is not
necessary. We propose an optimization approach that directly identifies a linear
combination of low level traits whose estimated heritability is high. This optimization
problem is formulated by decomposing the maximum likelihood method for estimating
the heritability of a quantitative trait. We develop an efficient sequential quadratic
programming algorithm to optimize the proposed formulation. We then extend the
basic formulation to take into account the effects of covariates so that the identified
trait has high heritability even after correction for the fixed effects. Because we do not
estimate any covariance matrix, our approach is computationally much more efficient
than those in [55, 38].
The proposed approach is validated in both simulations and a case study on
cocaine dependence. The effectiveness of the approach is demonstrated not only by
the higher cross-validated heritability of the derived traits than the existing methods
but also by a follow-up association study that compares the utility of the derived traits
with the commonly used phenotype. Specifically, a highly heritable multivariate trait
was derived for cocaine dependence. More statistically significant associations were
found for this trait than for a symptom-count phenotype, with successful replications
in an independent sample.
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4.2

Methods

Our formulation aims to solve the inverse problem of heritability estimation. Hence,
we first introduce the standard methods for heritability estimation. We then derive
our formulation that defines a linearly-combined trait by maximizing its heritability.
An efficient algorithm is then developed to optimize the formulation. At last, we
extend the approach to take into consideration of fixed-effect covariates.

4.2.1

Background: heritability estimation

We briefly review the well established maximum likelihood method that is based on
linear mixture models to estimate the heritability of a quantitative trait y [45, 4].
The method assumes that the phenotype yi of a family i follows a multivariate normal distribution with covariance Ωi and separate means for male and female family
members, µm and µf , respectively. Separate means are used for males and females
based on the general observation that males and females present differences in quantitative traits, such as height and weight. The (j, k)-th entry of Ωi is the phenotypic
covariance of two family members j and k, given by

cov(yji , yki ) = 2σa2 Φijk + σd2 ∆ijk + σe2 Γijk

(4.2.1)

where σa2 and σd2 are the variance components due to additive and dominant genetic
effects, respectively, and σe2 denotes the variance component due to environmental
factors. Eq. (4.2.1) can be extended to include other effects, such as an epistatic
genetic effect σI2 . The quantity Φijk is the kinship coefficient between members j and
k. It is the probability that two alleles randomly drawn from j and k at a genetic locus
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Table 4.2.1: Elements of the matrices Φ and ∆ for selected relationships in a family
when random mating is assumed.
Relationship
Same person
Parent-Child
Full-siblings
Half-siblings
Monozygous twins
Grandparent-grandchild
Uncle/aunt-nephew/niece
First cousins
Double first cousins
Spouses

Φ
1/2
1/4
1/4
1/8
1/2
1/8
1/8
1/16
1/8
0

∆
1
0
1/4
0
1
0
0
0
1/16
0

are identical by descent (IBD), i.e., that these two alleles are identical copies of the
same ancestral allele. An allele is one of the alternative forms at a genetic locus. As
the human genome is diploid, each individual has two copies of an allele that may differ
at a genetic locus. The quantity ∆ijk is the probability that members j and k share
both alleles at a genetic locus. Both matrices Φi and ∆i can be calculated from the
family pedigrees [4]. Exemplar entries of Φ and ∆ between selected family members
are illustrated in Table 4.2.1 where random mating is assumed. The parameter Γijk
is an environmental indicator that encodes whether j and k live together (Γijk = 1)
or apart (Γijk = 0).
The narrow sense heritability h2 = σa2 /σp2 where σp2 is the total variance in y, i.e.,
σp2 = σa2 + σd2 + σe2 . The broad sense heritability H 2 = (σa2 + σd2 )/σp2 . In this thesis
study, we target quantitative traits with higher narrow sense heritability, which we
henceforth refer to simply as heritability. However, our formulation can be easily
modified to derive a quantitative trait of high H 2 .
The five parameters, µm , µf , σa2 , σd2 and σe2 , are estimated by maximizing the log
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likelihood of pedigrees over all sample families [45]. The log likelihood is computed
by
LL =

X
i

1
1
i
i
− ln |Ωi | − (yi − µi )> Ω−1
i (y − µ ),
2
2

(4.2.2)

where µi denotes a vector of the means µm and µf for male or female members,
respectively, in the family i. The gradient and Hessian of Eq.(4.2.2) with respect
to µm , µf , σa2 , σd2 and σe2 can be calculated, and a Newton-Raphson algorithm or a
scoring method [45] can be applied to maximize the log likelihood Eq.(4.2.2).
The heritability of a quantitative trait y is often estimated with correction for
the effects of covariates z, such as age, sex, or race. These covariate effects are often
modeled as fixed effects on y. Thus, a linear regression model y = z> v +  can be
built where v indicates the combination weights for the covariates. The heritability
of the residual  is then estimated using the described maximum likelihood method
and treated as the heritability of y after adjusting for covariate effects.

4.2.2

Proposed quadratic optimization

In heritability estimation, a trait is given, and we search for the values of σa2 , σd2
and σe2 that maximize the likelihood of observing the trait values and compute the
heritability as σa2 /(σa2 +σd2 +σe2 ). In our study, we solve the inverse problem that a trait
must be derived so that its heritability is maximized when estimated by the method
described in the above section. For a given set of d phenotypic features x, we find a
linearly combined trait y : y = x> w that has a high estimate of heritability. Here,
we limit our discussion to linear combinations. However, the proposed method can
be used to create non-linear combinations by applying the so-called kernel mappings
to x [63].
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According to the discussion in the background section, if a trait y has the highest
possible heritability, the covariance of y among any family members in family i,
cov(yji , yki ), should be due to the additive effect σa2 only, and σd2 = σe2 = 0. In other
words, for such a trait, the covariance matrix of the phenotype yi of a family i relies
only on the additive effect parameter σa2 and the kinship matrix Φi , i.e., Ωi = 2σa2 Φi .
Thus σa2 is equal to the total variance σp2 of y. Now, this trait y is composed by x> w
from a set of features x, and w is the parameter to be determined. We thus need to
search for the values of w that maximize the likelihood of observing σd2 = σe2 = 0, or
in other words, that maximize the dependence of the covariance Ωi of a pedigree i on
the additive effect.
Let Xi be the data matrix on the d features for the subjects in family i. Then the
family’s trait values yi = X>
i w. Note that we can scale w so that the sample variance
of the derived trait is 1, which implies that σp2 = σa2 = 1. Substituting the values
of Ωi , yi and σa2 in the log likelihood in Eq.(4.2.2) yields the following maximization
problem:
max

w,µm ,µf

X
i

1
1
>
i > −1
i
− ln |2Φi | − (X>
i w − µ ) Φi (Xi w − µ ),
2
4

which is equivalent to the following minimization problem after eliminating constants

min

w,µm ,µf

X

>
i > −1
i
(X>
i w − µ ) Φi (Xi w − µ ).

(4.2.3)

i

Let β = [w> , µm , µf ]> , and Hi be defined by
>
Hi = [X>
i , [−1/0]im , [−1/0]if ]

where [1]i , [−1/0]im and [−1/0]if are column vectors with length equal to the number

66
of members in family i; [1]i consists of all 1’s. For males in the family, −1 is assigned
at their corresponding entries in [−1/0]im and 0 at other positions of the vector. The
vector of [−1/0]if is similarly defined for female family members. Then, we have
>
i
X>
i w − µ = Hi β, and Problem (4.2.3) can be rewritten as follows:

min β > (
β

X

>
Hi Φ−1
i Hi )β

(4.2.4)

i

Let H be the matrix by stacking all Hi in columns, then the sample variance of the
resulting trait is calculated as (1/n)β > HH> β. The scaling of w in that σp2 = 1
discussed above corresponds to a constraint β > HH> β − n = 0 in the formulation
. In fact, µm and µf are not free parameters, as they are determined once w is
determined. They are equal to the sample means of the trait, i.e., Mean(x> w), for
male and female, respectively, when the optimal w is found. Let µm , µf be the two
mean vectors of respective male and female samples on the features x. Both µm and
µf have a length of d. Let
>
>
>
am = [µ>
m , −1, 0] , af = [µf , 0, −1] ,

then the equality of µm = Mean(x> w) on all male subjects is translated into a>
m β = 0.
Similarly, we also have a>
f β = 0.
Imposing all of these constraints on Problem (4.2.4) yields an optimization problem where a quadratic objective needs to be minimized subject to both quadratic and
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linear equality constraints as follows:
min
β

β>(

X

>
Hi Φ−1
i Hi )β,

i

subject to

β > HH> β − n = 0,

(4.2.5)

>
a>
m β = 0, af β = 0.

According to statistical learning theory [74], optimizing only the empirical heritability on the training sample as in Eq.(4.2.5) will lead to the so-called overfitting
problem, which means that the resultant model y = x> w has low validation heritability despite a high training heritability. To enhance the generalizability of the
derived model to new samples, a regularization condition on w, R(w), is required to
control the complexity of the model. The objective function in Problem (4.2.5) thus
becomes
β>(

X

>
Hi Φ−1
i Hi )β + λR(w),

(4.2.6)

i

where λ is a pre-specified tuning parameter for balancing the two terms in the objective function, and R(w) can be realized in different forms and be application-specific.
P
For example, R(w) can be implemented with the `1 vector norm: ||w||1 = dj=1 |wj |,
which is known to create shrinkage effects on w as shown in the Least Absolute Shrinkage and Selection Operator (LASSO) method [70]. When features in x are clustered
in multiple groups and sparsity in each feature group level is desirable, R(w) can be
implemented by the `2,1 vector norm as used in the group LASSO [49] and defined by
P qP
2
||w||2,1 = L`=1
j∈G` wj where G` contains the indices of the features in the group
`.
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Specifically, we develop an algorithm in the next section to solve the following
optimization problem with the `1 norm regularization condition
min
β

subject to

X
>
β>(
Hi Φ−1
i Hi )β + λ||w||1 ,
i

β > HH> β − n = 0,

(4.2.7)

>
a>
m β = 0, af β = 0.

Note that Problem (4.2.5) is a special case of Problem (4.2.7) when λ = 0. Hence,
the solver for Problem (4.2.7) serves as a solver for Problem (4.2.5) as well.

4.2.3

Solving the proposed optimization problem

The objective function in Problem (4.2.7) is not differentiable because of the one-norm
regularization term. To convert it into an equivalent differentiable form so gradient
based solvers can be used, we introduce two sets of variables u ≥ 0 and v ≥ 0 both
of length equal to that of w. We set w = u − v. Correspondingly, we replace the
variables in β by:
γ = [u> , v> , µm , µf ]> .
>
>
Because X>
i w = Xi u − Xi v, we replace Hi by

>
>
Ki = [X>
i , −Xi , [−1/0]im , [−1/0]if ] ,

and let

>
>
>
b>
m = [µm , −µm , −1, 0] , bf = [µf , −µf , 0, −1] , J = [I2d×2d , [0]2d , [0]2d ],
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where I2d×2d is the identity matrix of dimension 2d×2d, and [0]2d is a column vector of
all zero entries with length of 2d. Then, we rewrite Problem (4.2.7) into the following
optimization problem

min
γ

subject to

2d
X
X
−1 >
γj
f :γ (
Ki Φi Ki )γ + λ
>

i

j=1

g1 : γ > KK> γ − n = 0,
g2 : b>
m γ = 0,

(4.2.8)

g3 : b>
f γ = 0,
g4:e : Jγ  0,
where e = 2d + 3 is the total number of constraints in the problem, and K is the
matrix by stacking all Ki in columns.
It can be mathematically proved that the optimal solution of Problem (4.2.8)
is identical to the optimal solution of Problem (4.2.7) in the sense that the optimal
Pd
P
γ
,
is
just
equal
to
w = u−v. Note that the regularizer in Eq.(4.2.8), 2d
j
j=1 (uj +
j=1
vj ). At optimality of Problem (4.2.8), either uj = 0 or vj = 0 for the jth feature
because otherwise they would not be optimal. If both uj > 0 and vj > 0 and assume
uj ≥ vj , then we have another solution, (ũj = uj − vj , ṽj = 0), that achieves lower
objective value than (uj , vj ) because the first term of f remains the same whereas the
second term of f becomes smaller. Thus, at optimality, the regularizer of Eq.(4.2.8)
P2d
Pd
Pd
j=1 γj =
j=1 (uj + vj ) =
j=1 |wj |.
Although Problem (4.2.8) is not a convex problem due to the quadratic equality
constraint g1 , we can solve it efficiently by the framework of sequential quadratic programming (SQP) [54]. The gradients of the objective function f and the constraints
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gi:i=1:e with respect to γ can be calculated as follows:
X
>
Of = 2(
Ki Φ−1
i Ki )γ + λc,
i

Og1 = 2(KK> )γ, Og2 = bm ,
Og3 = bf , Og4:e = c
>
where c = [[1]>
2d , 0, 0] and [1]2d is a column vector of all ones with length of 2d. The

Lagrangian function of this problem is:

L(γ, α) = f (γ) −

X

αi gi (γ)

(4.2.9)

i

where α contains all Lagrange multipliers. The Hessian of L with respect to γ is
calculated as:
O2γγ L = 2

X

>
>
Ki Φ−1
i Ki − 2α1 KK .

(4.2.10)

i

A SQP algorithm solves iteratively a sequence of quadratic programming subproblems, each formulated based on the current solution γ t and Lagrange multipliers αt .
At the iteration t + 1, it finds the searching directions for both γ and α by solving
the following quadratic program
min
p

subject to

1
f (γ t ) + Of (γ t )> p + p> O2γγ L(γ t , αt )p
2
Ogi (γ t )> p + gi (γ t ) = 0, i ∈ [1 : 3]

(4.2.11)

Ogi (γ t )> p + gi (γ t )  0, i ∈ [4 : e]
where p is the searching direction of γ, along which the objective function can be
decreased. Let p̂t be the solution to this subproblem and q̂t be the corresponding
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Algorithm 3 A sequential quadratic programming approach to solving Problem
(4.2.8)
Input: Ki , Φi , a0m , a0f , λ
Output: γ
1. Initialize γ with u = 1, v = 0, and µm , µf equal to the sample male and female
means of the obtained trait when w = 1.
2. Initialize α with α = 1.
3. Evaluate f , Of , Ogi and O2γγ L with the current γ and α.
4. Solve Problem (4.2.11) to obtain p̂ and q̂.
5. Perform line search to find the learning step size s.
6. Update γ and α as in Eq.(4.2.12).
Repeat 3-6 until γ reaches a fixed point.
optimal Lagrange multipliers of p̂t , the searching direction of α is calculated as q̂t −αt .
Then, a line search method, such as those described in [54], can be used to determine
the step size of moving along the directions. It then updates γ and α as follows:

γ t+1 = γ t + sp̂t , αt+1 = αt + s(q̂t − αt ).

(4.2.12)

Algorithm 3 summarizes the SQP algorithm that we developed to solve Problem
(4.2.8), and hence Problem (4.2.7).

4.2.4

Correction for covariates

As discussed in the background section, the heritability of a quantitative trait y with
effects from covariates z is equal to the heritability of the residual  of the linear
model y = z> v + . Therefore, our objective here is to find ŵ and v̂ that optimize the
heritability estimate of  :  = x> w − z> v, as y = x> w. Let Zp×n be the data matrix
on z of length p for the n subjects, the residual is calculated for all the subjects as
 = X> w − Z> v.
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Given the data Z and y, a linear regression model y = z> v is typically obtained
through a least squares method which has an analytical solution, v̂ = (ZZ> )−1 Zy.
As y = X> w, we have v̂ = (ZZ> )−1 ZX> w and

 = (X> − (ZZ> )−1 ZX> )w.

Let M = (X> − (ZZ> )−1 ZX> )> , which can be pre-calculated from data, the calculation of  can be rewritten as  = M> w. Then, the objective of optimizing the
heritability of  can be translated to finding the optimal w that gives an  of highest
estimate of heritability. Comparing to the problem of finding w that gives a trait
y = x> w with highest possible heritability, the only difference we have here is that
the design matrix has been changed from X to M for the parameters w. Therefore,
we can use the same algorithm that we have developed in the formulation section
to find the w that optimizes the heritability of . An interesting observation in our
derivation is that correcting a quantitative trait to account for covariant effects is
equivalent to correcting the data matrix that used to derive the trait.

4.3

Computational Results

The proposed approach was first validated in simulations where we compared it with
the current two-step approaches, i.e., estimating the two covariance matrices from
pedigrees first and then solving an eigenproblem. We compared with all the three
different methods that can be used to estimate the covariance matrices, which were
referred to, respectively, as Ott [55], Anova [56] and ML [38]. After the proposed
approach was validated in simulations, it was then used in a case study to analyze
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a real-world dataset that was aggregated from genetic studies of cocaine dependence
(CD) [25, 23]. Our algorithm was able to derive a quantitative trait with higher
heritability than that of commonly used CD phenotypes. To show how our approach
helped the association analysis, we compared the utility of the derived trait against
that of the symptom-count phenotype as traits in association analysis and replicated
the findings on a separate sample. The narrow sense heritability of all of the tested
traits in this study was estimated by the widely-used polygenic function in the Sequential Oligogenic Linkage Analysis Routines (SOLAR) program [3].

4.3.1

Synthetic data

In order to make our synthetic data more realistic but with known pattern, we created
the synthetic data based on family structures in the SSADDA dataset. In this dataset,
there were totally 6810 subjects, of which 1915 were from small nuclear families and
the rest subjects were unrelated individuals. Based on the family structures in this
data, we synthesized a quantitative trait y1 following the assumptions used in the
maximum likelihood method for heritability estimation. Specifically, the values of
y1 for each family were randomly drawn from a multivariate Gaussian distribution:
N (µ, Ω). The dimension of the distribution was determined by the number of subjects
in the family, such that each dimension corresponded to an individual in the family.
Note that the µ used in the simulation of each family may vary between families
according to the gender of the members. Precisely, if a family member is male, µ was
set to µm ; otherwise it was set to µf . The covariance matrix Ω was given as follows:
Ω = 2σa2 Φ + σd2 ∆ + σe2 I,

(4.3.1)
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where Φ and ∆ were composed according to Table 4.2.1. Without loss of generality,
in this study we used identity matrix I as the matrix Γ in Eq.(4.2.1). The quantitative
trait y1 was simulated with the following choices of the parameters:
[σa2 , σd2 , σe2 , µm , µf ] = [0.8, 0.1, 0.1, 0.9, 0.3].

(4.3.2)

Hence, 80% of the phenotypic variance was due to additive genetic effects, and the
ideal heritability is 0.8 according to Eq.(4.3.2). By the random nature of the simulation, the actual heritability of the simulated trait may vary a little.
In order to evaluate if our approach can correct for fixed effects of covariates, we
created another quantitative trait y2 based on y1 by adding effects from age and race.
Let α1 and α2 measure the effects of age and race respectively on y2 , we calculated y2
as follows: y2 = y1 + α1 × age + α2 × race. The values of the two α’s were arbitrarily
set to α1 = 1.1 and α2 = 0.7, (which can certainly be set to any other values). Using
SOLAR, we estimated the heritability of y1 with sex as covariate (h2 = 0.796) and
the heritability of y2 with sex, age, race as covariates (h2 = 0.797).
We next simulated phenotypic features (i.e., the low level traits) for the two quantitative traits y1 and y2 . We synthesized five datasets consisting of d =10, 20, 30, 40
and 50 phenotypic features respectively for each simulated trait. For each dataset,
we used the following procedure to create the features x and assign their weights w:
the values of the first d − 1 features were randomly drawn from the standard Gaussian distribution; then we assigned weights for each of the d features randomly; and
Pd−1
then the values of the last feature were computed by (y − j=1
wj xj )/wd (assuming
P
wd 6= 0). This procedure guaranteed that y = dj=1 wj xj . In practice, a multivariate
trait may not depend on all of the considered phenotypic features. In order to test if
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our approach can recover the relevant features, the assigned weights in w had 1, 21 ,
1 1
,
3 4

and

1
5

of the entries nonzero, respectively, for the five datasets. For instance, for

the dataset that had 40 features, only 10 of them were randomly assigned nonzero
weights and other weights were set to 0.
All the three methods which we compared with employed a regularizer in their
eigenproblem, so they also had a tuning parameter λ. On each dataset, the parameter
λ of all methods were tuned in the same three-fold cross validation process. More
specifically, for each dataset, we randomly split the sample into three groups, and
each group had the same amount of unrelated individuals and families with multiple
members whenever it was possible. Samples in each group were used in one of the
three folds, respectively, as the validation data to test the heritability of the trait
derived by a method from the rest of the samples. We repeated this three-fold cross
validation with 10 random splits for each choice of the λ values on each dataset. The
choices of λ were pre-specified to the range of [0, 50] with a step size 1. For each
method, the choice of λ that gave the best cross validated heritability was used in
the subsequent analysis.
We first examined some algorithmic behavior of the proposed approach. Figure
4.3.1 shows the three-fold cross validated heritability of the traits derived by our approach from the five datasets in the experiments with y1 . On all the five datasets,
the proposed method was able to identify the linearly-combined traits that were close
to y1 with a relatively wide range of λ choices. From Figure 4.3.1, we see that when
λ = 1, 1, 13, 18, and 18 respectively for the five datasets, the best validation heritability was obtained. This observation shows that when the underlying model gets
sparse, lager λ is favorable to prevent overfitting. We had similar observations in the
experiments with y2 as shown in Figure 4.3.2. Figure 4.3.2 plots the cross validated
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Figure 4.3.1: Cross validated heritability of derived quantitative traits in the
experiment with simulated trait y1 when λ varies from 0 to 50 with step size 1.
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Figure 4.3.2: Cross validated heritability of derived quantitative traits in the
experiment with simulated trait y2 when λ varies from 0 to 50 with step size 1.
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heritability obtained in the experiments with covariates and y2 . The validation heritability of the derived traits are high (with a little decrease when more irrelevant
features were experimented), which demonstrates that the proposed approach can
effectively correct for covariates in finding the heritable components.
Table 4.3.1: Cross validated heritability of the traits derived by the different methods in
the experiments without and with covariates.
Method
Proposed
Anova
Ott
ML
Proposed
ML

10 features
0.777(0.009)
0.638(0.063)
0.378(0.049)
0.755(0.020)
0.775(0.010)
0.708(0.097)

20 features
0.724(0.027)
0.581(0.043)
0.465(0.080)
0.046(0.032)
0.735(0.023)
0.044(0.037)

30 features
0.707(0.018)
0.430(0.042)
0.292(0.048)
−
0.738(0.030)
−

40 features
0.717(0.021)
0.551(0.050)
0.398(0.036)
−
0.708(0.031)
−

50 features
0.670(0.024)
0.447(0.060)
0.352(0.065)
−
0.644(0.051)
−

The “−” sign indicates that those experiments were not conducted due to prohibitive computation
cost.

We next examined the comparison of our approach against the state of the art.
To be more thorough, we compared all four methods using four different metrics
including validated heritablity, sum of squared residuals to the target trait y1 or y2
(SE(trait)), squared difference between the learned weights ŵ and the true weights
w, i.e., ||w − ŵ||2 (SE(w)), as well as the computation cost. Table 4.3.1 gives the
cross validated heritability of the traits derived by each of the methods in the two
sets of experiments with y1 and y2 . The performance was reported when the best λ
choice was used by each method. It is clear that the traits derived by our approach
always achieved the highest heritability.
Table 4.3.2 compares the values of SE(trait), SE(w), and the computation time in
seconds. In particular, the computational cost was measured by running each of the
methods on the full datasets without splits when the best λ value was used. Across all

ML
57.97
128.01
−
−
−
85.98
173.40
−
−
−

SE(w)
Proposed Anova
0.09
1.35
0.17
1.37
0.21
1.38
0.27
1.39
0.29
1.40
0.11
∗
0.18
∗
0.31
∗
0.29
∗
0.31
∗
Ott
1.38
1.39
1.48
1.44
1.43
∗
∗
∗
∗
∗

ML
1.34
2.54
−
−
−
1.35
2.58
−
−
−

Computation
Proposed Anova
0.61
0.17
0.85
0.19
0.90
0.19
0.98
0.29
2.13
0.30
0.86
∗
1.07
∗
1.30
∗
1.61
∗
2.52
∗

Time
Ott
0.11
0.15
0.14
0.23
0.26
∗
∗
∗
∗
∗

(sec.)
ML
8.24e+02
1.16e+04
−
−
−
8.85e+02
1.20e+04
−
−
−

The “−” sign indicates that those experiments were not conducted due to prohibitive computation cost. The “∗” sign indicates that
the corresponding methods were not tested due to the limitation of the methods that could not handle covariates. The computation
time reported for the ML method was measured when the maximum number of iterations was set to 200.

Dataset

SE(trait)
Proposed Anova Ott
10 features 10.89
59.03 67.44
20 features 16.62
60.83 63.08
30 features 19.69
63.03 72.46
40 features 23.31
62.71 68.39
50 features 25.23
64.22 67.23
10 features 13.61
∗
∗
20 features 16.14
∗
∗
30 features 26.60
∗
∗
40 features 26.81
∗
∗
50 features 25.87
∗
∗

Table 4.3.2: Comparison of the methods on the sum of squared residuals (SE(trait)), squared difference of the true
weights and the learned weights (SE(w)), and the computation time (in seconds) in the experiments without and with
covariates.
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of the datasets, our approach obtained the smallest errors among all the methods as
measured by SE(trait) and SE(w). Because Anova used analytic formula to compute
covariance matrices, and Ott used a single locus in the covariance estimation, both
methods required slightly less computation cost than our approach. However, they
were limited only to the situations that had no confounding factors in heritability
calculation. Between the two more comprehensive methods, our approach was significantly more efficient than the ML method in computation, making the heritable
component analysis with a large number of phenotypic features feasible.
Our approach could identify multivariate traits of much higher heritability than
the commonly used traits. We compared the heritability of the traits derived by our
approach with that of individual phenotypic features and the simple average of all
features. We used the traits derived by our approach from the cross validation process
when the best λ values were used. As shown in Figure 4.3.3 (without covariates) and
4.3.4 (with covariates), the validation heritability of the derived traits were significantly higher than the heritability of any individual feature and the trait by averaging
all features.
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Figure 4.3.3: Comparison between the trait derived by the proposed approach,
individual features and the simple average of features in the experiment with simulated
trait y1 . Heritability was estimated without taking into account covariates. The maximum
among the heritabilities of individual features is taken and shown in the figure.
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Figure 4.3.4: Comparison between the trait derived by the proposed approach,
individual features and the simple average of features in the experiment with simulation
trait y2 . Heritability was estimated taking into account the covariate effects. The
maximum among the heritabilities of individual features is taken and shown in the figure.
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4.3.2

A case study: cocaine use and related Behaviors

We applied the proposed approach to a real-world problem represented by genetic
studies of cocaine use and related behaviors. Two independent sets of samples were
used in our analysis: the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) dataset [25], which was used for discovery and was the one our
simulation study in previous section based on; and the Study of Addiction: Genetics
and Environment (SAGE) dataset [52], which was used for replication. The SSADDA
subjects were recruited from multiple sites, including the University of Connecticut
Health Center, Yale University School of Medicine, the University of Pennsylvania
School of Medicine, McLean Hospital and the Medical University of South Carolina.
All subjects gave written, informed consent to participate, using procedures approved
by the institutional review board at each participating site. A total of 6810 subjects
were used in our analysis, including 1922 individuals from small nuclear families, with
the remainder being unrelated individuals. We included unrelated individuals in our
analysis to estimate phenotypic variance even though they had no effect on the covariance estimate. The SAGE data were aggregated from multiple NIH-funded projects
[10], and downloaded from a public domain [52]. It consisted of 58 individuals from
nuclear families and 1603 unrelated individuals. All subjects in the two datasets were
from one of two populations: African American (AA) or European American (EA).
All involved subjects were reported to have used cocaine in their lives, which were
assessed on the following 13 features of cocaine use and related behaviors:
• F1 - tolerance to cocaine;
• F2 - withdrawal from cocaine;
• F3 - using cocaine in larger amounts or over longer period than intended;
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• F4 - persistent desire or unsuccessful efforts to cut down or control cocaine use;
• F5 - great amount of time spent in activities necessary to obtain, use or recover
from the effects of cocaine;
• F6 - gave up or reduced important social, occupational, or recreational activities
because of cocaine use;
• F7 - cocaine use despite knowledge of persistent or recurrent physical or psychological problems likely to have been caused or exacerbated by cocaine;
• F8 - number of cocaine symptom endorsed;
• F9 - age when first used cocaine;
• F10 - age when last used cocaine;
• F11 - age when first being diagnosed with DSM4 cocaine dependence;
• F12 - age when last being diagnosed with DSM4 cocaine dependence;
• F13 - transition time in years between the first time cocaine use and the first
cocaine dependence diagnosis.
Features F1-7 were binary variables that take a value of “yes=1” or “no=0”. F8-13
were continuous variables, which we normalized to the range of [0, 1] in the analysis.
The majority of the 6810 subjects interviewed with SSADDA, were genotyped
on a illumina microarray for 988,306 autosomal single-nucleotide polymorphisms
(SNPs). Genotypes for additional 37,427,733 SNPs were imputed using IMPUTE2
[35] with genotyped SNPs and 1000 Genomes reference panel released in June 2011
(http://www.1000genomes.org). Both subjects and SNPs were under through stringent quality control (refer to [25] for details). There were in total 4,845 subjects
(2674 AAs, 2171 EAs) and 30,078,279 SNPs (695,308 genotyped) remained for analysis. Top three ancestral principal components were computed using 145,472 SNPs
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that were common to discovery samples and Hapmap panel. All of the 1661 subjects
(640 AAs, 1021 EAs) in replication dataset were genotyped for 1,072,657 SNPs.
We derived a composite trait based on the 13 features of cocaine use and related
behaviors. This trait was derived using discovery data and Algorithm 1 with correction of the effects of covariates age and race. As in simulation study three-fold
cross validation was performed to find optimal λ, which was subsequently used to
find a linear combination of the 13 features and derive a trait using the entire discovery data. The heritability of obtained trait was estimated and compared to that of
individual quantitative features in the data, including cocaine symptom count(F8),
which was recognized as a better trait than the binary cocaine dependence diagnosis
in the study hunting for genetic risk factors [25]. We applied the learned linear model
to replication data. The heritability of derived trait on replication samples was not
estimated because 97% of the sample consisted of unrelated individuals. Associate
tests were firstly performed on discovery samples for both derived trait and cocaine
symptom count. The associations with p-value less than 5 × 10−6 were further tested
using replication samples. Association tests were performed separately for AA and
EA. All tests included age, sex and the first three ancestral principle components
as covariates. The association test results on discovery and replication data were
combined by performing meta analysis using Metal [81].
The heritability of generated traits for λs from 1 to 50 with step size 1 is plotted in
Figure 4.3.5. When λ = 2, the resulted traits have the highest heritability on average
in the cross validation comparing to other choices of λ. Hence, we chose λ = 2
and used it in Algorithm 1, which was then applied to the entire discovery sample
to obtain a composite trait and its linear model. The heritability of resulted trait
together with that of all individual quantitative features are reported in Table 4.3.3.
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Figure 4.3.5: Validation heritability of the composite traits derived by our approach for
cocaine use and related behaviors using different values of λ.
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Table 4.3.3: Heritability estimates for the composite trait derived by the proposed
method and all individual quantitative features in the data.
Traits
Trait derived by proposed method
Cocaine symptom count
Age when first used cocaine
Age when last used cocaine
Age when first CD diagnosis
Age when last CD diagnosis
Transition time between first
cocaine use and CD diagnosis

heritability
0.70
0.41
0.39
0.45
0.43
0.38

p-value
4.36 × 10−22
1.52 × 10−08
2.41 × 10−09
6.70 × 10−06
1.15 × 10−10
5.99 × 10−09

standard deviation
0.06
0.07
0.07
0.10
0.07
0.07

0.42

8.09 × 10−10

0.07

The composite trait derived by our approach has the highest heritability estimate
among all the traits.
Due to the use of the sparsity-favoring `1 -norm regularization, our approach selects
features to use in the linear model. Figure 4.3.6 shows the weights of the features
obtained in our model. Five of 13 features had weight 0, thus were removed from
the model. The feature of age when first used cocaine received the largest positive
weights and therefore had the largest impact on the obtained trait. The other four
features that had significant impact on the obtained trait were F11 - age onset of
DSM4 CD diagnosis; F4 - persistent desire or unsuccessful efforts to cut down or
control cocaine use; F5 - great amount of time spent in activities necessary to obtain,
use or recover from the effects of cocaine; and F3 - using cocaine in larger amounts
or over longer period than intended. Features F6, F1 and F2 had limited effect on
the resulted trait. The values of the derived trait computed on the discovery sample
are shown in Figure 4.3.7.
We identified three SNPs for the AA population and four SNPs for the EA population that passed our p-value threshold in the genomewide association tests with
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Figure 4.3.6: Weights of the eight clinical features in the linear model of the composite
trait derived by our approach to the evaluation of cocaine use and related behaviors.

the discovery sample. The top findings are listed in Table 4.3.4. These SNPs were
found significantly or nominally significantly associated with the trait derived by the
proposed approach at the genomewide level, but not significantly associated with the
cocaine symptom count. In other words, using the standard phenotype in the association tests would not discover these SNPs that are associated with a specific subtype
(a quantitative subphenotype) of cocaine dependence. Among the seven SNPs in Table 4.3.4, four (one: rs833936 for AA, three: rs11079045, rs7224135 and rs10490394
for EA) were significantly associated with the derived trait in the replication study
with meta-analysis p-values < 10−7 . The marker rs833936 is located at the TXNIP
gene whose expression is suppressed by synaptic activity in brain [6]. Both markers rs11079045 and rs7224135 are located at the PTRF gene which was identified to
be associated with cocaine abuse in an early transcriptional change study [47]. The

88

500
Group 2

450

Number of subjects

400
350
300
250
200

Group 1

150
100
50
0
0

2

4

6
8
Quantitative scores

10

Figure 4.3.7: Distribution of the trait values computed on the discovery sample.
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EFEMP1 gene has not been reported in the genetic analysis of cocaine dependence.
Since all the identified SNP markers have not been thoroughly studied in genetics
of cocaine dependence, our findings may promote subsequent investigations for these
genes as well as subtypes of cocaine dependence. The proposed heritable component analysis for multivariate phenotypes may provide a new strategy to improve
genomewide association studies of complex disorders.

Gene
MAF

pderived

Discovery
psymp

17 PTRF 0.40
17 PTRF 0.40
2 EFEMP1 0.20
13 DACH1 0.39

2.48 × 10−6
7.61 × 10−7
8.78 × 10−7
7.50 × 10−6

2.24 × 10−1
1.50 × 10−1
1.53 × 10−1
6.00 × 10−2

6 DNAH8 0.26 6.14 × 10−6 9.62 × 10−2
1 TXNIP 0.36 7.90 × 10−8 2.51 × 10−2
11 MLSTD2 0.06 1.89 × 10−6 1.85 × 10−1

Chr
pderived

psymp

0.42
0.41
0.19
0.34

1.48 × 10−3
2.29 × 10−3
9.15 × 10−3
2.81 × 10−2

2.24 × 10−1
1.50 × 10−1
1.53 × 10−1
6.00 × 10−2

0.03 8.74 × 10−3 3.58 × 10−2
0.12 2.22 × 10−2 1.76 × 10−2
0.35 4.95 × 10−2 5.60 × 10−1

MAF

Replication

psymp

1.33 × 10−8
6.51 × 10−9
3.22 × 10−8
8.00 × 10−7

1.82 × 10−1
1.08 × 10−1
2.33 × 10−1
2.80 × 10−3

1.85 × 10−7 1.57 × 10−2
5.59 × 10−9 2.43 × 10−3
2.70 × 10−7 1.48 × 10−1

pderived

Meta

Chr, chromosome; MAF, minor allele frequency; pderived , p-value on the trait derived by the proposed method; p-value on cocaine
symptom count. SNPs: rs769065, rs833936 and rs75621732 were tested using their close linkage equilibrium (LD) proxies: rs12215108
(602 bp downstream), rs4636400 (1004 bp upstream) and rs1730833 (80 bp upstream), respectively in replication data, because these
SNPs were not available in this data. For these SNPs, the corresponding MAFs in the table belong to their proxies. SNPs and p-values
that reach genome-wide significant level (< 5 × 10−8 ) are in bold font.

rs11079045
rs7224135
EA
rs10490394
rs7330895

rs769065
AA rs833936
rs75621732

SNP

Table 4.3.4: Top findings in genome-wide association study.
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4.4

Summary

In this chapter, we have proposed a quadratic optimization formulation that is capable
of identifying highly heritable composite traits of complex phenotypes. The composite
trait is derived as a linear function y = x> w of lower level traits x by explicitly
maximizing its heritability. Specifically, we search for the optimal w that maximizes
the likelihood of observing a high value of heritability. This is equivalent to finding the
best w, so that the projected trait x> w will be best aligned with the kinship matrix
Φ of the pedigree. An efficient algorithm based on sequential quadratic programming
has been developed to optimize the proposed formulation. The algorithm is extended
to allow the correction for covariate effects when deriving a composite trait.
Our simulation study proves the effectiveness of the proposed approach as a means
to find highly heritable composite traits. Then a case study on the complex phenotypes of cocaine use and dependence was conducted. A composite trait was identified
based on eight cocaine use symptoms and behaviors. The trait had a heritability
estimate of 0.52 (with p = 6.47 × 10−12 , std = 0.07), which was much higher than
a standard cocaine-use phenotype, i.e., the symptom-count trait, with heritability
of 0.4. The subsequent phenotype-genotype association study demonstrated greater
utility of the derived trait than the standard phenotype for use in association analysis. Our results show that three of the four associated SNPs were more significantly
associated with the derived trait, and two of them were replicated in an independent
data set.
Our formulation has a hyper-parameter λ. Using a hyper-parameter is common
in machine learning algorithms such as support vector machines [73]. As a hyperparameter, λ is not determined by solving the formulation itself and instead needs
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to be pre-specified. Both our simulation study and our case study showed that our
formulation is fairly robust to the value of λ when it is chosen from a reasonably
wide range. In real-world applications, hyper-parameters are often determined by a
cross-validation process, which was used in our experiments.
The proposed approach may be useful to enhance animal or plant breeding programs that aim to improve genetic selection of a conceptual, economically important
phenotypes such as feed efficiency or heat tolerance. Our approach can be used to
derive new composite traits by combining a variety of lower-level traits that are used
to measure the conceptual phenotype. These new composite traits will have much
higher heritability than that of currently used. The heritability of the breeding trait is
considered to be one of the most important factors for the performance of a breeding
program.
There are limitations of our proposed technique. The non-convex quadratic optimization formulation requires a complex solver, such as sequential quadratic programming. For a sample that contains millions of subjects, it may become computationally
prohibitive. More efficient solvers or approximations may be needed to scale up the
proposed approach. In some applications, complex grouping structures may exist in
the data between different lower-level traits. A formulation that takes into account
the special data structure may be more useful in producing biologically and clinically
meaningful traits. As discussed in the chapter, alternative regularization conditions
exist, including some that may deal well with complex data structures, such as the
one based on `2,1 vector norm. Algorithms that can solve the formulations with alternative regularization terms need to be developed. Additional empirical studies across
different disciplines are needed to evaluate the power of the proposed approach.

Chapter 5
Identifying Heritable Composite
Traits with Genome-Wide SNPs
for Complex Phenotypes

5.1

Introduction

In order to use the approaches we have described in Chapter 4 to identify heritable
subtypes from phenotypic features, family members are required in the study. However, on one hand it is difficult to collect data for multi-member families in large
scale. For example, in the largest GWAS for CD to date [25], only around 1,200
subjects with African American ancestry are from nuclear families, while there are in
total 4,121 African Americans in the study. On the other hand, with the availability
of dense genotype data, now it is possible to estimate genetic relationship among
subjects using genome-wide SNPs, and also the narrow-sense heritability, h2 of a
trait under interest. The h2 estimated from unrelated individuals using genome-wide
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single nucleotide polymorphisms (SNPs) is so called “chip heritability”. In fact, it
has been argued that estimating h2 from unrelated individuals has advantage over
traditional pedigree-based approaches because the estimated h2 corresponds only to
the causal-variant heritability that is tagged by genotyped SNPs [83, 65]. Thus, it
is of great interest to develop a method that can identify heritable composite trait
from phenotypic variables using unrelated individuals and their genotype data for
genome-wide SNPs.
In this chapter, we propose such an approach. To estimate chip heritability
of a given trait, recently-published methods use the restricted maximum likelihood
(REML) method assuming the trait follows a mixed effect model with random genetic
effects and fixed effects due to covariates [83, 65]. To identify a trait of high chip heritability, we solve the inverse problem of (chip) heritability estimation. In other words,
we search for a linearly-combined trait when estimating the trait’s chip heritability
using the REML method, the estimate is high. Directly solving the inverse problem
leads to a quadratic optimization problem that can be optimized efficiently via a sequential quadratic programming algorithm. We validate the proposed approach on
both synthetic and real world data. Our experimental results show the effectiveness
and generalizability of the proposed approach.

5.2
5.2.1

Method
Background: chip heritability estimation

Given a set of n subjects, we use a vector y of length n to denote their trait values
for a quantitative trait y, a matrix Zn×m to represent their standardized genotypic
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data at m genetic variants, and Cn×p to represent their data on p covariates. The
matrix Z is calculated from the genotypic data as follows. Let fj be the frequency
of reference allele at the j-th genetic variant, rij be the number of copies of reference
allele that i-th subject has at j-th variant, and then the standardized genotype zij is
p
calculated as (rij − 2fj )/ 2fj (1 − fj ). The well known chip heritability estimation
method [83] considers the following linear mixture model that characterizes how a
phenotype is related to genotypes and covariates:

y = Cβ + Zu + ε,

(5.2.1)

where ε is a vector of length n, which specifies residual effects. In Eq.(5.2.1), all
covariates have fixed effects (fixed β) on the phenotype whereas genetic effects are
random (random u). Assume u and ε follow Gaussian distributions: u ∼ N (0, Iσu2 )
and ε ∼ N (0, Iσe2 ). Then, the variance of y, denoted by Ω, can be calculated as:
Ω = ZZT σu2 + Iσe2 .

(5.2.2)

Let σg2 be the phenotypic variance attributable to all m genetic causal variants in Z.
Then, we have σg2 = mσu2 . Let G = ZZT /m be the genetic relationship matrix (GRM)
among subjects determined by the causal variants, Eq. (5.2.2) can be re-written as:

Ω = Gσg2 + Iσe2 .

(5.2.3)

σg2 and σe2 can be estimated by the REML method [58, 84]; and the heritability
contributed by the m causal variants is computed as h2 = σg2 /σp2 , where σp2 = σg2 + σe2
is the overall phenotypic variance. Because the causal variants are usually unknown
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for a trait, recent research has proposed to use genome-wide SNPs in estimating a
GRM [83, 65].
The main idea of REML is to project y with a set of n basis represented by
columns in a matrix Ln×n . This matrix can be decomposed into two matrices: L1n×p
and L2n×(n−p) with L = [L1 L2 ], LT1 C = Ip×p and LT2 C = 0. Then LT y follows the
multivariate Gaussian distribution as following:


  

T
T
T
L1 y
β  L1 ΩL1 L1 ΩL2 

 ∼ N   , 
 .
LT2 y
0
LT2 ΩL1 LT2 ΩL2
Let ỹ = LT y, ỹ1 = LT1 y and ỹ2 = LT2 y, we have ỹ2 ∼ N (0, LT2 ΩL2 ) and the
conditional distribution:

ỹ1 |ỹ2 ∼ N β + LT1 ΩL2 (LT2 ΩL2 )−1 ỹ2 , (CT ΩC)−1



Then, the log likelihood of ỹ can be decomposed into:

`(σg2 , σe2 ; ỹ) = `2 (σg2 , σe2 ; ỹ2 ) + `1 (σg2 , σe2 ; ỹ1 |ỹ2 ).
Notice that here, `2 is not a function of β. The two variance components, i.e., σg2 and
σe2 are estimated by maximizing `2 , because β and ỹ1 are of equal length, so there is
no further information in `2 for estimating the variance components.
`2 is calculated as (excluding constants, i.e., terms without σg2 and σe2 ):
1
`2 (σg2 , σe2 ; ỹ2 ) = − (ln |LT2 ΩL2 | + ỹT2 (LT2 ΩL2 )−1 ỹ2 ).
2
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It has been shown in [75] that when LT1 C = Ip×p and LT2 C = 0, we have:
Ω − ΩL2 (LT2 ΩL2 )−1 LT2 Ω = C(CT Ω−1 C)−1 CT .

With this equality, the calculation of `2 can be written as:
1
`2 (σg2 , σe2 ; ỹ2 ) = − (ln |Ω| + ln |CT Ω−1 C| + yT Py),
2

(5.2.4)

where P = Ω−1 − Ω−1 C(CT Ω−1 C)−1 CT Ω−1 . Maximizing Eq.(5.2.4) leads to the
estimates of σg2 and σe2 , which are denoted by σˆg 2 and σˆe 2 , respectively [84]. Once σg2
and σe2 are estimated, a generalized least square estimate of β can be obtained as:
β̂ = ỹ1 − LT1 ΩL2 (LT2 ΩL2 )−1 ỹ2 ,

which can be reduced to:

β̂ = (CT Ω−1 C)−1 CT Ω−1 y.

(5.2.5)

Also the chip heritability of the trait y can then be computed using the two variance
estimates, i.e., σˆg 2 and σˆe 2 .

5.2.2

Proposed problem formulation

When estimating chip heritability, we find optimal σˆg 2 and σˆe 2 that maximizes Eq.(5.2.4)
with given y, C and Z. However, in the inverse problem, a definitive quantitative
trait y is not known beforehand but needs to be derived from a set of phenotypic
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variables. Let Xn×d be the data matrix of d phenotypic variables for the same n
subjects as in Z, a trait y is defined by a linear function y = Xw. Unlike the heritability estimation process that finds the best values of σg2 and σe2 to maximize the
likelihood of observing the values of y, the inverse problem searches for the best w
so to form a trait y that maximizes the likelihood, (or equivalently the log likelihood
`(σg2 , σe2 ; y, C, Z)), of observing a large heritability, i.e., a large σg2 but small σe2 . For
simplicity and easy interpretation of the resultant model, here we only consider linear models, but the proposed method can be easily extended to construct non-linear
models through kernel mapping [74].
Notice that the highest possible heritability of a trait y is 1 when σg2 = 1 and
σe2 = 0. We propose to formulate an optimization problem, in which we search for an
optimal w that maximizes `(σg2 , σe2 ; y, C, Z) where y = Xw, and σg2 = 1 and σe2 = 0.
Substituting the values of these parameters into the log likelihood and removing
constants yield the following objective function:

min
w

wT (XT PX)w

(5.2.6)

where P is calculated as:

P = G−1 − G−1 C(CT G−1 C)−1 CT G−1 .

(5.2.7)

Since σg2 = 1 and σe2 = 0, the phenotypic covariance matrix Ω = G (based on
Eq.(5.2.3)).
Because σp2 = σg2 + σe2 , when σg2 = 1 and σe2 = 0, we have σp2 = 1. This requires to
impose a constraint to the optimization problem so that the total phenotypic variance
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that is due to either genetic or environmental effect should be 1. An estimate of σp2
can be obtained by calculating the sample variance after correcting for the covariates
effect as follows:
σ̂p2 =

1
(Xw − Cβ)T (Xw − Cβ)
n

As an estimate of β can be calculated as in Eq.(5.2.5), substituting its value and also
letting
J = I − C(CT Ω−1 C)−1 CT Ω−1 ,
the calculation of σ̂p2 can be written as σ̂p2 = (1/n)wT XT (JT J)Xw. To further simplify
the notation, letting
Q = (1/n)JT J,

(5.2.8)

we have σ̂p2 = wT (XT QX)w. Combining the objective function and the constraint
together, the proposed optimization problem is formulated as:
min
w

subject to

wT (XT PX)w
(5.2.9)
T

T

w (X QX)w = 1

We now regularize the linear model by introducing a regularizer on w which aims
to avoid the overfitting problem. If overfitting occurs, the optimal w of Problem
(5.2.9) may correspond to a trait that has high heritability on the data that is used
to train the linear model, but when the model is applied to a new sample, the resultant
trait has low heritability. In order to prevent overfitting and identify a trait with high
heritability that can generalize, we incorporate a regularizer R(w) in the formulation.

100
The optimization problem becomes:
min
w

subject to

wT (XT PX)w + λR(w)
(5.2.10)
T

T

w (X QX)w = 1,

where λ is a hyper-parameter and needs to be pre-determined. It can either be chosen
by users according to domain knowledge or determined using cross-validation as in the
experiments conducted in this paper. According to learning theory [74], minimizing
wT (XT PX)w corresponds to empirical risk minimization, whereas minimizing the
objective in Eq.(5.2.10) corresponds to structural risk minimization that improves
the generalizability of the resultant model. There are many different ways to realize
P 2
R(w) [68]. The kwk22 norm defined by kwk22 =
i wi is a common choice. The
P
kwk1 norm defined by kwk1 = i |wi | is a better choice when more model sparsity is
required to select less variables for use in the model. In more complicated applications
where variables may be grouped and feature selection among groups is expected, a
P qP
2
structured regularizer, such as the group lasso ||w||2,1 = L`=1
i∈G` wi , can be
used where G` contains the indices of variables belonging to a group `.

5.2.3

Solving proposed problem

In this thesis study, we realize R(w) by the kwk1 norm and develop an efficient
algorithm to solve the resultant optimization problem as follows:
min
w

subject to

wT (XT PX)w + λkwk1
(5.2.11)
T

T

w (X QX)w = 1.
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The algorithm we will describe next, although is designed for Problem (5.2.11), can
be modified to solve Problem (5.2.10) that takes another form of the above-discussed
regularization.
Due to the kwk1 norm, the objective function in Problem (5.2.11) is not continuously differentiable and a gradient decent type of approach cannot be applied
directly. A well known strategy to overcome this obstacle is to decompose w into
two parts: w = u − v, both u and v are vectors of the same size as that of w; and
all the components in u and v are required to be non-negative. Let γ = [uT , vT ]T
and H = [X, −X]. By the change of variables, Problem (5.2.11) can be equivalently
re-written as:

min
γ

subject to

f : γ T (HT PH)γ + λ

2d
X

γi

i=1

g1 : γ T (HT QH)γ − 1 = 0

(5.2.12)

g2:e : γ  0,
where f denotes an objective function, g’s denote constraints, and e = 2d + 1, indicating the number of constraints in that group. It is easy to show the equivalence
between Problems (5.2.12) and (5.2.11). When Problem (5.2.12) reaches optimality,
at least one of the two components ui and vi at any i-th position of the two vectors
will exactly be 0. Otherwise, by setting ũi = ui − vi and ṽi = 0 if ui ≥ vi , or ũi = 0
and ṽi = vi − ui if ui < vi , we obtain a better solution with ũi and ṽi . Therefore,
the optimal ŵ to Problem (5.2.11) can be derived from the optimal γ̂ to Problem
(5.2.12) by setting ŵ = û − v̂.
Problem (5.2.12) is not a convex problem because of the quadratic equality constraint. However, it can be efficiently solved using sequential quadratic programming
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(SQP) algorithm [54] because both of the objective and constraints are either in a
quadratic or a linear form. The gradient of the objective and constraint functions
with respect to γ can be calculated as:
Of = 2(HT PH)γ + λ1,
Og1 = 2(HT QH)γ,
Og2:e = I.
Let α be the Lagrange multipliers, the Lagrangian function of this problem can be
written as:
L(γ, α) = f (γ) +

X

αi gi (γ);

i

and the Hessian with respect to γ is computed as:

O2L = HT 2(P + α1 Q)H.

We iteratively search for the optimal solution to Problem (5.2.12). In each iteration, we first solve the following quadratic program to find the moving direction for
γ and α,
min
p

subject to

1
f (γ t ) + Of (γ t )> p + p> O2 L(γ t , αt )p
2
Og1 (γ t )> p + g1 (γ t ) = 0,

(5.2.13)

Ogi (γ t )> p + gi (γ t )  0, i ∈ [2 : e].
The optimal solution p̂ to this problem will give the next moving direction for γ,
along which the objective of Problem (5.2.12) can be decreased. Let q̂ be the optimal
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Algorithm 4 A sequential quadratic programming approach to solving Problem
(5.2.11)
Input: Z, C, X, λ
Output: γ
1. Calculate P according to Eq.(5.2.7), and Q according to Eq.(5.2.8).
2. Initialize γ with u = 1, v = 0.
3. Initialize α with α = 1.
4. Evaluate f , Of , Ogi and O2 L with the current γ and α.
5. Solve Problem (5.2.13) to obtain p̂ and q̂.
6. Perform a line search to find the learning step size s.
7. Update γ and α as in Eq.(5.2.14).
Repeat 4-7 until γ reaches a fixed point.
Lagrange multipliers corresponding to p̂. The next moving direction of α is calculated
as q̂ − αt . With the moving direction being calculated, we then employ a line search
method [54] to find the optimal learning step size s and update γ, α as follows:

γ t+1 = γ t + sp̂t , αt+1 = αt + s(q̂t − αt ).

(5.2.14)

We summarize the proposed algorithm in Algorithm 4.

5.3

Computational Results

We validated the proposed approach in both simulations and the analysis of a realworld data set that was aggregated from multiple genetic studies of cocaine dependence (CD). Following the design principle for the chip heritability simulations in
[83], we used real genotypic data in the CD study in our simulations but synthesized
phenotypes. We first give a thorough description about our CD study data.
In the CD study, subjects were recruited from multiple sites, including the Uni-
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versity of Connecticut, Yale University School of Medicine, the University of Pennsylvania School of Medicine, McLean Hospital and the Medical University of South
Carolina. All subjects participated using procedures approved by the institutional review board at each participating site. There were 6,621 subjects genotyped at totally
1,140,420 SNPs genome-wide. Among them, 2,674 were stratified into the African
American population, and only these subjects were used in our experiments to avoid
spurious findings due to population structure. We removed 537 subjects who have
other family members in the data so GRM was computed for unrelated individuals.
A series of data cleaning steps were performed to insure the quality of genotypic
markers. Markers that meet any of the following conditions were excluded: low
call rate (< 98%), G/C and A/T markers (to avoid strand issues), deviating from
Hardy-Weinberg equilibrium (p < 1e − 8), significant cohort calling discrepancy and
monomorphic. We also removed non-autosomal markers, so only markers from the 22
autosomal chromosomes were used in the analysis. After these data cleaning steps,
690,864 were SNPs remained. Genetic relationship was estimated for each pair of
subjects using the software called GCTA [84] and all the 690,864 SNPs. We then
further excluded 385 subjects whose relatedness with some subjects was greater than
0.025 (corresponding to the relatedness of second cousins). Eventually, 1,752 subjects
were used in our analysis.
We first validated the proposed approach using synthetic data that was created
based on the cleaned CD study data. Then we applied our approach to the real
clinical features that characterize the cocaine use behavior of the subjects. For both
simulation and the CD case study, we ran 10 times three-fold cross validation (CV)
to determine a proper value of λ. At each fold of the CV, a linear model was derived
by running the proposed method on training data, and then applied to test data.
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Testing h2 of the composite trait model was estimated only using subjects in the
test data. We ran the CV for multiple choices of λ (see figures for the choices we
used) and chose the one that gave a trait with the highest testing h2 . Once λ was
determined, we ran the proposed method on the entire sample set to identify the final
trait. All the reported h2 was estimated using GCTA with a GRM computed with
the 690,864 SNPs. We compared the heritability of the trait derived by our approach
with that of the cocaine symptom counting phenotype which has been recognized
as a better composite trait than CD diagnosis in genetic studies [25]. Moreover, in
order to understand better the composite trait resulted from our approach, we studied
the quantitative scores that all the subjects obtained for the trait; and we show the
characteristics of subject subgroups partitioned based on their quantitative scores on
important cocaine use related variables.

5.3.1

Synthetic data

We first simulated a quantitative trait y based on the linear mixed model as shown
in Eq.(5.2.1). From the 690,864 SNPs, we randomly picked 2,000 to use as the causal
variants of the simulated trait. Each component ui in u was generated independently
by sampling from the standard normal distribution, i.e., N (0, 1). Each component
εi in ε was created from the normal distribution with mean of 0 and variance of
var(zi u)(1/h2 − 1), where zi is the i-th row in Z, var(.) is the sample variance of
a random variable and h2 is the implanted heritability. In our simulation, we set
h2 = 0.8. Once u and ε were determined, we added the effect from the covariates
to generate the final trait. Three covariates were used in our study, including: age,
sex and the first principle component (PC) of the GRM in the CD study data, their
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effect was arbitrarily specified as -0.2, 0.1, and 0.1, respectively. The resultant y has
a h2 estimate of 0.86(s.e. = 0.27).
Then we simulated phenotypic data on seven variables (i.e., the X) based on y
created above. In order to simulate the real world situation where w is sparse, three
out of the seven variables were created with impact on y, while the other four with no
impact. The w in y = Xw was created by assigning random values in the range of
(0, 2) to the three variables with impact and 0 to the rest four variables. We randomly
drew values for all the variables except one with impact on y (which was randomly
picked) from the standard normal distribution. Date for the left out variable was
P
generated with value of (yi − 2j=1 wj xij )/w3 , where w1 and w2 were weights of the
two variables with impact, and for which data were randomly created, w3 was the
weight of the left out variable. We estimated the h2 for all the seven simulated
variables. The results are reported in table 5.3.1. The maximum heritability was
0.17. By simulating the data in this way, we know that there is at least one linear
combination of variables in the data that results in a composite trait with h2 of 0.86.
Hence, if our approach works, it should at least find this linear combination if there
is no any other combination that gives a trait with even higher h2 , so our approach
should find a trait of h2 ≥ 0.86.
We performed 10 times three-fold cross validation for 20 different λ’s ranging from
1 to 20 with step size 1. Besides the test h2 was estimated for each trait model in
the CV, we also estimated their training h2 to have a full view of how h2 changes
when λ varies. The training and testing h2 ’s are plotted in Figures 5.3.1 and 5.3.2,
respectively. Both of them have the highest value when λ = 1, with a median of
0.85 for training and 0.6 for testing h2 . When λ increases, both training and testing
h2 drop, but the testing h2 changes only slightly when λ varies between 1-6. We

107
Table 5.3.1: Heritability estimates of the seven simulated variables

Variable h2 s.e.
V1
V2
V3
V4
V5
V6
V7

0.12
0
0
0
0.17
0.14
0

0.27
0.26
0.26
0.26
0.27
0.26
0.26

also observed from Figure 5.3.3 that less number of variables remained in the model
when λ increased. This showed that more redundant variables were excluded from
the model.
When λ = 6, the traits derived in the CV had training h2 very close to those
developed when λ < 6 on average, but used less number of variables in the model,
thus reducing the risk of overfitting. We hence chose λ = 6 when we developed the
final trait with the entire sample set. The h2 estimate of the resultant trait is 0.94
(s.e. 0.27), and it is larger than that of the trait we implanted. Moreover, it is
larger than the h2 estimate of any individual trait. These results demonstrate the
effectiveness of the proposed approach in identifying heritable composite trait from
complex multivariate phenotype.

5.3.2

A case study: cocaine use and related behaviors

All the 1,752 subjects were interviewed with a computer-assisted form, the SemiStructured Assessment for Drug Dependence and Alcoholism (SSADDA) [59], which
consists of questions designed for cocaine use and related behaviors. The responses to
these questions lead to the definition of seven important cocaine use related variables,
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Figure 5.3.1: Simulation study: the training h2 of the composite traits developed in
three-fold cross validation with varying λ.

based on which a diagnosis of CD is determined. These seven variables are listed
below:
• F1 - tolerance to cocaine;
• F2 - withdrawal from cocaine;
• F3 - using cocaine in larger amounts or over longer period than intended;
• F4 - persistent desire or unsuccessful efforts to cut down or control cocaine use;
• F5 - great amount of time spent in activities necessary to obtain, use or recover
from the effects of cocaine;
• F6 - gave up or reduced important social, occupational, or recreational activities
because of cocaine use;

109

Mean
Median

Heritability

0.8
0.6
0.4
0.2
0
1

3

5

7

9

11

λ

13

15

17

19

Figure 5.3.2: Simulation study: the testing h2 of the composite traits developed in
three-fold cross validation with varying λ.

• F7 - cocaine use despite knowledge of persistent or recurrent physical or psychological problems likely to have been caused or exacerbated by cocaine.
In our experiments, positive responses to the seven variables are coded with 1 otherwise 0. In previous study [25], the counting of symptoms related to cocaine use has
been shown as a better trait than the binary trait induced by the diagnosis of CD
for use in genetic association studies. Cocaine symptom counting is defined as the
number of positive responses to the seven variables. In other words, it is a composite
trait resulted from the linear combination of the seven variables with equal weights.
Our objective was to identify a linear combination of the same seven variables that
led to a trait with a higher h2 estimate than that of the cocaine symptom counting.
Since all the seven variables are binary, their h2 s were not estimated here.

# of none zero weights
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Figure 5.3.3: Simulation study: the number of variables used in linear combinations
constructed by the proposed method in cross validation with different choices of λ.

We also performed 10 times three-fold CV for λ’s ranging from 1 to 20 with step
size 1. In all these expriments, we used age, sex and the first three PCs of the GRM
as covariates. The testing h2 s of all traits derived in the CV are plotted in Figure
5.3.4. When λ = 4, resultant traits have the highest heritability estimates on average
with a mean of 0.29. We set λ = 4 and developed a trait by running the proposed
method on the entire sample set. The h2 estimate of the resulted trait is 0.30 (s.e.
0.27). We also estimated the heritability for cocaine symptom counting using exactly
the same sample set, GRM and covariates. It has a h2 estimate close to zero. These
results again demonstrate the effectiveness of our approach in identifying heritable
composite trait from complex multivariate phenotype.
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Figure 5.3.4: Case study on cocaine dataset: the testing h2 of the composite traits
derived in three-fold cross validation with varying λ.

The weights that each variable obtained in the linear combination obtained by
our approach with λ = 4 and the entire sample set are show in Figure 5.3.3. Out of
the seven variables, three (F3, F5 and F7) received zero weight, and were completely
ruled out from the model. Another three variables (F2, F4, F6) received weights
that were significantly deviated from 0, thus had the most impact on the resultant
trait. Among these three variables, F2 and F4 had positive weight, which implies that
positive responses to these two variables would result in high scores for the resultant
trait; whereas F6 had a negative weight, which means a positive response to this
variable would result in a low score. Variable F1 had a weight of 0.0026, and had
very limited impact on the trait comparing to F2, F4 and F6.
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F2: Withdrawal from cocaine
F4: Persistent desiring or unsuccessful cutting down cocaine use
F6: Gave up or reduced important activities because of cocaine use
F1: Tolerance to cocaine
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F5: Great amount of time spent in activities related to cocaine
F7: Cocaine use despite knowledge of problems likely caused by cocaine
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Figure 5.3.5: Case study on cocaine dataset: the weights of variables in the linear
combination learned by the proposed method with λ = 4 and the entire sample set.

Figure 5.3.6 shows the distribution of scores (trait values) that subjects obtained
for the composite trait derived by our approach with λ = 4 and the entire sample set.
Based on the scores, the sample could be partitioned into three groups as shown in
Figure 5.3.6. There were 222 subjects (12.67% of total) in group 1, which had a mean
score of -1.61. Group 2 was the largest one consisting of 1358 subjects, and took up
77.51% of the entire sample set. The mean score of this group was 0.39. Group 3 had
the least number of subjects, that was 172 (9.82%), with a mean score of 2.59.
In order to understand better the derived trait, we characterized the three groups
using important clinical variables related to cocaine use. Besides the seven variables
that we have used in deriving the trait, we included another four important variables:
(1) total number of cocaine symptoms endorsed (i.e., the cocaine symptom counting);
(2) age when first time used cocaine; (3) age when first being diagnosed with DSM-IV
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Figure 5.3.6: Case study on cocaine dataset: the distribution of scores for the composite
trait derived by the proposed method with λ = 4 and the entire sample set.

CD; (4) the transition time in years from first time cocaine use to first DSM-IV CD
diagnosis. The results are summarized in Table 5.3.2. Noteworthy findings include:
no subject in Group 1 had withdraw symptom from cocaine while all subjects in
Group 3 had it; no subject in Group 3 ever gave up or reduced important activities
because of cocaine use while all subjects in Group 1 had such an experience; and
subjects in Group 2 had the largest number of cocaine symptoms endorsed, and
longest transition time from the first cocaine use to first diagnosis of CD among the
three groups.

Tolerance to cocaine
Withdrawal from cocaine
Using cocaine in larger amounts or over longer period than intended
Persistent desiring or unsuccessful cutting down cocaine use
Great amount of time spent in activities related to cocaine
Gave up or reduced important activities because of cocaine use
Cocaine use despite knowledge of problems likely caused by cocaine
Number of cocaine symptoms endorsed
Age when first used cocaine
Age onset of DSM-IV cocaine dependence
Transition time in years from first cocaine use to first CD diagnosis

N (%) is shown for the first seven binary variables, where N is the number of subjects who are positive on the corresponding variable
within a group and % is the percentage of N in the group.
µ(σ 2 ) is shown for the last four continuous variable, where µ is the group mean and σ 2 the standard deviation.

84(48.84)
172(100.00)
139(80.81)
162(94.19)
122(70.93)
0(0.00)
133(77.33)
4.72(1.06)
23.33(8.96)
28.23(8.37)
7.78(14.54)

111(50.00)
0(0.00)
191(86.04)
214(96.40)
181(81.53)
222(100.00)
197(88.74)
5.03(0.97)
22.31(6.59)
28.52(7.99)
7.48(11.38)

Variable

939(69.15)
1122(82.62)
1161(85.49)
1245(91.68)
1132(83.36)
1122(82.62)
1181(86.97)
5.82(1.99)
21.64(5.97)
27.13(7.09)
12.22(20.93)

Group1
Group2
Group3
222(12.67) 1358(77.51) 172(9.82)

Table 5.3.2: Characteristic of the three subject groups on important clinical variables related to cocaine use.
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5.4

Summary

We have developed an approach that identifies composite traits from multivariate phenotypes that are highly heritable as estimated based on genome-wide SNPs. The trait
we derived is in the form of linear combination of variables related to the phenotype,
that is y = Xw. A quadratic optimization problem has been formulated, in which
optimal w is sought to optimize the log likelihood for estimating variance components
in REML. In this formulation, variance components are set to their ideal values with
the additive genetic variance component σg2 equal to 1 and other components equal
to 0. To overcome the issue of overfitting, we incorporate a regularization term in our
formulation. An efficient algorithm based on the sequential quadratic programming
framework has been developed to solve the proposed optimization problem. We have
evaluated the proposed approach on both synthetic and real world data. The empirical results demonstrate the effectiveness of our approach as it identifies traits with
much higher chip h2 than commonly-used disease phenotypes.
In this study, the pairwise genetic relationship among subjects was estimated from
genome-wide SNPs. However, it can certainly be estimated from SNPs restricted to
a specific region, such as a particular chromosome or genes related to a pathway, to
explore the genetic architecture of a trait. When SNPs within a specific region are
used, the trait resulted from the proposed approach will achieve the maximized genetic
variance component corresponding to this region. In an application, such as substance
dependence, there are known pathways involved in the biological mechanism of the
disorder, it may be interested to find out whether there is a composite trait, the
variance of which can be largely explained by the variants within these pathways,
which will be a future application of our approach.
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